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10   IntroductionGENERAL INTRODUCTION AND OUTLINE OF THIS THESIS
 Surgical options, risks and benefits
Colorectal cancer is a major source of morbidity and mortality and has 
an increasing incidence with more than 12,000 patients diagnosed in 
the Netherlands in 2013.1  The treatment of colorectal cancer requires 
a multidisciplinary approach, although surgical resection is still the 
cornerstone of treatment. In the Netherlands, yearly approximately 
10,000 patients undergo a curative resection because of colorectal 
cancer.2 
 Nevertheless, curative surgery for colorectal cancer comes at a 
price. Postoperative complications are frequent, including anastomotic 
leakage which is a serious complication causing re-operation, a 
prolonged hospital stay, morbidity, a possibly worse oncological outcome 
or even mortality.3-5  Also, functional loss of continence and sexual 
impairment after rectal cancer surgery cause both short- and long-term 
morbidity. 6,7
 When in rectosigmoid cancer tumour size, localization, and 
stage of disease allow a sphincter preserving procedure, an (low) 
anterior resection is performed. The surgical options after resection 
include a primary anastomosis, an anastomosis with a defunctioning 
stoma, and an end-colostomy (Figure 1). Each of these surgical options 
is associated with specific benefits and risks. Both patients and surgeons 
seem to have a strong preference to avoid a stoma, under the assumption 
that it will have negative consequences for quality of life.8,9 On the other 
hand, poor functional outcome after a low anastomosis, especially in 
combination with radiotherapy or chemo radiation, can also lead to an 
impaired quality of life. 
 A defunctioning stoma has been proven to diminish chances of 
anastomotic leakage or its sequelae.10 Furthermore, anastomotic leakage 
will not occur when an anastomosis is avoided, e.g. when an end-
colostomy is constructed. 
 The benefits of preventing or minimizing anastomotic leakage 
should however always be balanced against the risks of the alternatives. 
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A defunctioning stoma itself carries a substantial risk of becoming 
permanent.11,12 Furthermore, stomas may also have significant mid-to 
long-term morbidity when the patient is discharged from the hospital or 
after reversal of the stoma.11-15 
 Patient information and Shared Decision Making
The decision on anastomosis or stoma construction after surgical 
resections for rectosigmoid cancer consists of a trade-off between pros 
and cons of different treatment options. Therefore, it is an appropriate 
situation for investigating preoperative information provision and 
Shared Decision Making (SDM).
 In recent years, the concept of SDM has gained widespread 
appeal to both clinicians and patients.16,17 In SDM, clinicians and 
patients make decisions together using the best available information. 
SDM is considered especially important for patients who present with a 
serious illness such as cancer, when the outcomes are uncertain, or when 
different treatment options are available.18 Previous studies have shown 
that patients with colorectal cancer prefer to be involved in the decision 
making process and to be informed on the risks of different treatment 
options.19
 Surgical treatment strategies
With a growing demand for public transparency of performance in the 
last decade, surgeons and hospitals are increasingly accountable for 
their postoperative complication rates. An awareness of the problem 
of anastomotic leakage together with surgeons’ growing accountability 
for their outcomes could have led to changes in strategies in colorectal 
cancer surgery and a more routine use of (defunctioning) stomas after 
low anterior resection. Not all patients however benefit from a stoma, as 
there are several drawbacks that counterbalance its advantages.11,13,20,21 
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Clear guidelines on which surgical strategy to use in different groups 
of patients are not yet available. When there are 2 or more generally 
accepted and effective treatment options, selection of the appropriate 
treatment should be based on patient preferences. Previous research 
however suggests that for many conditions treatment selection depends 
more on the physician’s recommendation than on patient characteristics 
or preferences.22 Consequently, differences in professional opinion may 
lead to variation in treatment patterns, which has been demonstrated 
for several conditions in various parts of the world.23-30 The threshold 
for the decision to construct a stoma to avoid the risk of anastomotic 
leakage may also vary between surgeons. Some surgeons may be more 
risk-taking or -averse than others. This may lead to a variation between 
hospitals in surgical strategy concerning anastomosis and stoma 
construction. 
 Quality assessment 
Although colorectal surgery is performed often, it is considered high-
risk surgery as it brings along a relatively high risk of complications. 
Therefore, colorectal surgery is focus of different quality enhancement 
programs.31-33 In the Netherlands, The Dutch Surgical Colorectal Audit 
(DSCA) was successfully initiated in 2009 with the objective to evaluate 
and improve quality of care for primary colorectal cancer surgery.  
Measurement of outcomes may in itself improve surgical outcomes – as 
suggested by the so-called “Hawthorne effect”: colleagues can learn 
from each other by addressing specific differences in clinical practice 
and outcome.4 In time, specific processes can be recognized that are 
associated with a high likelihood of good outcomes, the so-called ‘best 
practices’.  
 Postoperative mortality is frequently used in hospital 
comparisons as an indicator for quality of care. When comparing 
mortality rates between hospitals, there is an important role for risk 
adjustment.4,5 Observed variations in mortality may partly be caused by 
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differences in patient and tumour characteristics (case-mix). High risk 
patients may not be evenly distributed between hospitals.6 However, 
valid case-mix adjustments require a considerable amount of reliable 
data collected at the patient level. These data are rarely available and 
require a substantial registration effort. Therefore, it may be valuable 
to identify outcome measures that are less influenced by differences 
in case-mix and represent the actual differences in quality of care 
processes, such as anastomotic leakage. 
 The overall aim of this thesis is to investigate several aspects of 
clinical decision-making and outcome assessment in colorectal cancer 
surgery
 Outline of this thesis
Part I: Risks, benefits, and decision-making 
The first part of this thesis studies short and long term risks of a 
primary anastomosis after colorectal resections, an anastomosis with a 
defunctioning stoma and an end-colostomy, and investigates how these 
risks are communicated in surgical practice. In Chapter 1, we performed 
a systematic review of studies describing anastomotic leakage and the 
associated mortality in comparison to the overall postoperative mortality 
after low anterior resection for rectal cancer. Chapter 2 investigates 
the postoperative and one-year outcomes of anastomosis with and 
without a defunctioning stoma or end-colostomy after resection of mid 
rectal cancer in seven Dutch hospitals. Chapter 3 focusses on surgeons’ 
opinion on necessary preoperative information for rectosigmoid cancer 
patients and evaluates what is actually communicated in practice. 
Gastroenterological surgeons’ attitudes towards Shared Decision Making 
were assessed and compared with patient involvement in current 
practice.
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Part II: Surgical treatment strategies
The second part of this thesis mainly focuses on current surgical 
treatment strategies in colorectal cancer surgery, with regard to 
stoma and anastomosis construction. In Chapter 4, current use of 
defunctioning stomas after low anterior resection was assessed, and 
compared with the use of defunctioning stomas at the time of the TME-
trial, together with associated outcomes. In Chapter 5, differences in 
professional opinion regarding the use of defunctioning stomas were 
analyzed, and investigated whether there was variation in treatment 
patterns between hospitals in the Netherlands.  In Chapter 6, we assessed 
whether a tendency to anastomosis or stoma construction was related to 
postoperative outcomes such as anastomotic leakage and mortality rates.
Part III: Quality assessment of Colorectal Surgery
In the third part of this thesis, different aspects of clinical auditing as a 
tool for quality assessment of colorectal cancer surgery were studied. Chapter 
7 illustrates the introduction of the Dutch Surgical Colorectal Audit in the 
Netherlands by describing its main features and presenting the results of 
three years of auditing. Chapter 8 describes the role of anastomotic leakage 
as an outcome measure for quality of colorectal surgery. In this chapter, it 
was explored whether hospital differences in anastomotic leakage rates were 
related to differences in case-mix. 
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Figure 1. Surgical options after resection of the tumour in colorectal cancer (a) 
include a primary anastomosis (b), an anastomosis with a defunctioning stoma 
(c), and an end-colostomy (d).
A    B
C    D
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Chapter 1: 
META-ANALYSIS OF THE RISK FOR 
ANASTOMOTIC LEAKAGE, THE POSTOPERATIVE 
MORTALITY CAUSED BY LEAKAGE IN RELATION 
TO THE OVERALL POSTOPERATIVE MORTALITY.
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 Abstract 
Introduction: Availability of anastomotic leakage rates and mortality 
rates following anastomotic leakage is essential when informing patients 
with rectal cancer preoperatively. We performed a meta-analysis of 
studies describing anastomotic leakage and the subsequent postoperative 
mortality in relation to the overall postoperative mortality after low 
anterior resection for rectal cancer. 
Methods: A systematic search was performed of the published literature. 
Data on the definition and incidence rate of AL, postoperative mortality 
caused by AL, and overall postoperative mortality were extracted. Data 
were pooled and a meta-analysis was performed.
Results: Twenty-two studies with 10343 patients in total were 
analyzed.  Meta-analysis of the data showed an average AL rate of 
9%, postoperative mortality caused by leakage of 0.7% and overall 
postoperative mortality of 2%. The studies showed variation in 
incidence, definition and measurement of all outcomes. 
Conclusion: We found a considerable overall AL rate and a large 
contribution of AL to the overall postoperative mortality. The variability 
of definitions and measurement of AL, postoperative mortality caused 
by leakage and overall postoperative mortality may hinder providing 
reliable risk information. Large-scale audit programs may provide 




When discussing treatment options for rectal cancer with patients 
preoperatively, difficult considerations can be encountered. Besides 
tumour and patient related factors, both doctors and patients’ 
preferences play a role in the decisions about treatment options. This 
is particularly the case in surgical treatment for rectal cancer, when 
deciding between constructing an anastomosis and/or creating a stoma.  
Both patients and doctors have a strong preference to avoid a stoma, 
under the assumption that it will have negative consequences on quality 
of life.1 
 On the other hand, an anastomosis may not be beneficial to 
all patients, as a considerable proportion of patients with rectal cancer 
report defecation problems following a low anastomosis, such as fecal 
incontinence and urgency.2 Even more important is considering the 
risk of anastomotic leakage (AL) following the construction of an 
anastomosis. AL is the most frequent major complication after surgery 
for rectal cancer, causing re-operations, prolonged hospital stay, 
morbidity, mortality and possibly a worse oncological  outcome.3
Recent advances in surgical techniques have increased options for 
sphincter preservation in rectal cancer. The increasing use of sphincter 
preserving procedures subsequently exposes more patients to the risk of 
anastomotic leakage.4 In order to inform and involve patients in clinical 
decision-making, clinicians need reliable and accurate information on 
AL rates and mortality rates following AL. Previous studies have shown 
that patients with rectal cancer prefer to be involved in the decision 
making process and to be informed on risks of different treatment 
options5.
 The aim of this study was to perform a systematic review of 
studies describing anastomotic leakage and the associated mortality in 
comparison to the overall postoperative mortality after low anterior 
resection (LAR) for rectal cancer. Regarding the difference in impact 
and consequences for a patient, it is important to distinguish clinically 
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relevant anastomotic leakage from radiologic leakage.1 In this review we 
assessed clinical anastomotic leakage. 
 Methods
Literature search
Relevant studies published between January 1990 and August 2011 were 
identified by searching Medline, Embase and The Cochrane Library 
databases. The following search terms were used: AL, dehiscence, 
mortality, anterior resection, mesorectal excision. Both free text search 
and MeSH search for keywords were employed. Two investigators (HS 
and BB) independently performed the literature search. To increase 
the sensitivity of the search strategy, the ‘related article’ function was 
used, and reference lists of relevant articles were searched for additional 
relevant studies. The search was restricted to publications in English.
Study selection and data extraction
All randomized controlled, multi-center and single-center, prospective 
and retrospective studies describing surgical therapy for rectal cancer 
were considered for inclusion. Studies were included when describing 
patients undergoing elective LAR for rectal cancer. The articles had 
to contain at least data on 1) AL rates 2) mortality following AL and 
3) overall mortality. Only articles describing all three outcomes were 
included. Only original articles were included in order to maintain 
adequate details on patient selection, study design, methods and 
outcome, allowing for accurate comparison of the study results. 
Studies were excluded from analysis when they also described patients 
that underwent emergency resections, high anterior resections, 
abdominoperineal resections, procedures other than for rectal cancer 
and experimental surgical techniques such as robot-assisted surgery.
We extracted data on the definition and incidence rate of AL, 
postoperative mortality caused by AL and overall postoperative 
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mortality. No rating of these studies was performed; al studies were 
accepted or rejected based on the criteria noted above. Data were 
extracted independently by two different researchers and compared. Any 
discrepancies were resolved by discussion. 
Statistical analysis
The percentages of AL, postoperative mortality following leakage and 
overall postoperative mortality were meta-analyzed with a random 
effects model. Because the numbers were small in most studies, we 
applied the method of Hamza et al.6  The standard deviations of the 
random effect was zero, therefore data could be pooled.  The overall 
percentages of the outcomes were therefore the number of events over 
studies divided by the total number of patients over studies.
Statistical analyses were carried out in PASW Statistics, Rel. 18.0.2009 
(SPSS inc., Chicago, Il, USA) and R 2-14 (The R Project for Statistical 




We identified 188 studies of which 22 were included.3,7-26 One hundred 
and sixty six studies did not meet the inclusion criteria and were 
excluded from further analysis. The most common reason for exclusion 
was that the study described also other types of surgery without 
providing specific data on the outcomes of LAR alone (n=69). Twenty-
eight studies were excluded because they did not mention all three 
outcome measures. Reasons for exclusion are shown in table 1. 
The included studies had a total population of 10343 patients. Sample 
sizes of studies varied from 38 to 2726 patients. There were two 
randomized controlled trials investigating the effect of a defunctioning 
stoma on AL rates. The other studies were non-randomized (table 2).
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Anastomotic leakage: incidence and definition.
For the meta-analysis we used the number of ALs as defined in the study. 
The overall AL rate was 9% (974 out of 10343 patients). There was a large 
variation in AL rates; the highest reported AL rate was 28% and the lowest 
reported rate was 3% (figure 1).
 AL was described in 19 of 22 studies. Three studies gave no 
definition of AL, fourteen studies gave a detailed description of the 
definition of AL and the remaining studies gave only a limited definition. 
Most definitions of AL consisted of a clinical suspicion based on the 
patient’s symptoms. The reported symptoms comprised the signs of 
localized or generalized peritonitis (10 studies), fecal discharge from the 
wound and/or drain (9 studies), abscess (10 studies), recto-vaginal fistulas 
(6 studies), purulent discharge from drain, wound and leukocytosis (1 
studies). The need for active intervention was used in some studies to 
define a clinically relevant AL, whereas others accepted signs of leakage 
without further intervention. None of the authors provided a grading 
system to classify the severity of AL (table 3). 
Overall mortality: incidence and definition
For the meta-analysis we used the number of postoperative deaths as was 
described in the study. The mean overall postoperative mortality rate was 
2% and varied from 0 to 8% (figure 2). 
 The definition of postoperative mortality differed. Two studies 
specified postoperative mortality as death within 30 days after operation, 
both in-hospital and after discharge. One study considered all in-hospital 
deaths as postoperative mortality. Five studies reported postoperative 
mortality as all patients who died within 30 days after surgery and gave no 
further specification of the location (in-hospital or after discharge). Three 
studies included all in-hospital deaths in the postoperative mortality rate, 
without specification of timing. Nine studies described postoperative 
mortality without specification of location (in-hospital or after discharge) 
or timing. Two studies did not specify their definition of mortality.
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Postoperative mortality caused by AL: incidence and definition.
For the meta-analysis we used the number of postoperative mortality 
caused by ALs as defined in the study. In total, 71 out of 10343 patients 
died as a direct consequence of AL (0.7%), ranging from 0 to 5%. One 
third of the overall mortality was caused by AL.  This ratio ranged from 
0 to 100% (figure 2).
 Nine studies defined postoperative mortality caused by AL as 
‘death of septic complications secondary to AL’. Five studies defined 
postoperative mortality caused by AL as ‘all deaths after anastomotic 
leakage’. No study reported details on how causes of death were 
determined, for example autopsy findings. The remaining studies 
reported no postoperative deaths in patients with AL (table 3). 
 Discussion
In this thorough overview of studies describing anastomotic leakage and 
subsequent mortality after low anterior resection for rectal cancer we 
found that patients have a considerable risk for AL (9%). We found that 
AL considerably contributed to mortality after rectal cancer surgery, 
accounting for one third of all postoperative mortality. This finding 
is supported by, and could well be compared with, the results of a 
nationwide population based study assessing exclusively patients who 
died following anterior resection of the rectum28. The study describes 
140 patients that died following rectal excision with anastomosis, of 
whom 42% had anastomotic leakage, a result very similar our findings.
 The information of the present study may very well be used 
for counseling patients preoperatively. However, we also found that 
the definitions of AL and postoperative mortality varied widely. The 
twenty-two included studies used twelve different definitions to describe 
AL.  The lack of universally accepted definitions for AL has already 
been described in 2001 by Bruce et al29. They described 29 separate 
definitions for AL after lower gastrointestinal surgery. The author plead 
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for the use of a standard definition that could distinguish between clinical 
minor and major leaks.   
 We also found six different definitions of overall postoperative 
mortality. The timing (30-days or 90-days) or location of death (in-
hospital mortality or death after discharge) varied. Recent evidence shows 
that mortality almost doubles by 90 days when compared with the rate 
at 30 days in patients undergoing colorectal surgery30. This clarifies the 
importance of a uniform agreement on measurement of postoperative 
mortality. 
 Average rates of AL, postoperative mortality and mortality as a 
result of AL all showed a wide range between the different publications. 
This may be a reflection of differences in definition, as well as actual 
differences in performance. 
 
 Surgical treatment for rectal cancer is embedded with difficult 
decision, often subject to both doctors and patients’ preferences. 
The variability of definitions and variance in outcome rates between 
studies may hinder providing patients with reliable risk information 
preoperatively. 
 Obviously, AL and its subsequent mortality will never occur 
if an anastomosis is avoided, e.g. when a permanent end colostomy 
is constructed. In the case of choosing the anastomosis there is today 
strong evidence for adding a defunctioning stoma in order to reduce the 
risk for clinical leakage.31  The benefits of preventing or minimizing AL 
should always be balanced against the disadvantages of the alternatives. 
A defunctioning stoma itself carries a substantial risk of becoming 
permanent either as a loop stoma32 or as a permanent loop ileostomy 
or a permanent end colostomy.33,34 Also, different studies report that 
stomal complications are prevalent, as they are seen in 25 to 50% of 
patients with a stoma after 8-10 years of follow-up.35,36 Furthermore, the 
morbidity and mortality of closure of a defunctioning stoma should be 
taken into account.37 On the other hand, if AL occurs in patients without 
a deviating stoma, it often requires re-operation, and also creation of a 
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secondary stoma. Last, the effect of a treatment on quality of life should 
be considered. Opposed to the negative influence of a stoma on quality 
of life, patients with (low) anastomoses also have a risk for functional 
derangements, incontinence, sexual and bladder functions. All these 
factors should be balanced against each other and taken into account in 
the final decision.  
 This decision would be easier if we could select those patients 
with a higher risk for AL and subsequent mortality. Predicting AL 
enhances the possibility to take precautions to prevent it, or diminish 
its consequences. The percentage of patients developing AL depends 
on multiple factors. Several patient-, tumour-, and therapy-related 
parameters have been identified as risk factors for AL in a large amount 
of studies. A disturbed microcirculation, as seen in nicotine abuse or 
diabetes mellitus patients, has been said to increase the risk for AL38,39 
Also, height of the anastomosis, preoperative radiation, a malnourished 
status, steroid use, male gender and peri-operative bleeding are 
previously described potential risk factors.40 Unfortunately, despite the 
vast body of evidence on the potential risk factors, AL remains difficult 
to predict in an individual patient. As the selection process of high-
risk patients remains imperfect, we emphasize that every single patient 
should be counseled preoperatively on the risk of AL, the consequences 
including mortality and the possibility of stoma formation. 
 The available literature however, is insufficient to inform 
patients on AL and subsequent mortality and make the trade-off 
between an anastomosis (with or without defunctioning stoma) or a 
permanent end colostomy. 
 Ideally, to support clinical decision making in current surgical 
practice, this meta-analysis would also provide information on AL and 
the subsequent mortality risk in subgroups of patients, such as patients 
treated with preoperative radio- or chemotherapy or patients with a 
defunctioning stoma. However, an important inclusion criterion in our 
analysis was the availability of data on AL, mortality due to AL and 
overall mortality.  Most articles did not stratify all these three outcomes 
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for individual subgroups; therefore meta-analysis within these subgroups 
was not possible. The lack of availability of this data further emphasizes 
the limitation of current evidence on anastomotic leakage rates for the use 
in daily clinical decision making.
 Therefore, more research is needed, one of the most important 
things being uniformity of definitions. Recent growing public interest 
in quality and outcome of medical and surgical care has led to the 
development of audit programs. These guarantee uniformity of definition 
and measurement of basic outcome parameters such as AL, subsequent 
postoperative mortality and overall postoperative mortality.  Frequent 
feedback of these outcomes may support clinicians when informing 
patients about risks of different treatment options and facilitates the 




Table 1: Studies excluded from the meta-analyses.
Reason for exclusion    Number of studies (n)
Other types of surgery included   69
Not all three outcome criteria mentioned   28
Surgical procedures other then for 
rectal cancer included    14
Only abstract available    13
Review of the literature    13
Described also non-curative resection   6
Also emergency situations included   5
Described  new surgical technique    8
to avoid leakage      
Other      9
Total      165
Table 2: Characteristics of the included studies.
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HIGH ONE-YEAR COMPLICATION 
RATE AFTER LOW ANTERIOR 
RESECTION FOR RECTAL CANCER.
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 Abstract 
Introduction: Surgical options after low anterior resection for rectal 
cancer include a primary anastomosis, anastomosis with a defunctioning 
stoma and an end-colostomy. This study describes short-term and one-
year outcomes of these different surgical strategies.
Methods: Patients undergoing surgical resection for primary mid and 
high rectal cancer were retrospectively studied in seven Dutch hospitals 
with one-year follow up. Short term endpoints were postoperative 
complications, re-interventions, prolonged hospital stay and mortality. 
One-year end-points were unplanned readmissions and re-interventions, 
presence of stoma and mortality.
Results: Nineteen per cent of 388 included patients received a primary 
anastomosis, 55% an anastomosis with defunctioning stoma, and 27% 
an end-colostomy. Short-term anastomotic leakage was 10% in patients 
with a primary anastomosis vs. 7% with a defunctioning stoma (P=0.46).  
An end-colostomy was associated with less severe re-interventions. 
One-year outcomes showed low morbidity and mortality rates in 
patients with an anastomosis. Patients with a defunctioning stoma had 
high (18%) readmissions and re-intervention (12%) rates, mostly due to 
anastomotic leakage. An end-colostomy was associated with unplanned 
re-interventions due to stoma/abscess problems. During follow-up, there 
was a 30% increase in patients with an end-colostomy.
Conclusion: This study showed a high one-year morbidity rate after 
low anterior resection for rectal cancer. A defunctioning stoma was 
associated with a high risk for late complications including anastomotic 
leakage. An end-colostomy is safe alternative to prevent anastomotic 
leakage, but stomal problems cannot be ignored. Selecting low-risk 




Colorectal cancer is a significant source of mortality with more than 12.000 
cases diagnosed in the Netherlands each year.1  The cornerstone of 
treatment is surgical resection. 
 When discussing surgical treatment options for rectal cancer 
with patients preoperatively, difficult considerations can be encountered. 
When tumor size, stage and location allow a sphincter preserving 
resection, the surgical options consist of an anastomosis, an anastomosis 
with a defunctioning stoma and an end-colostomy. Both patients and 
surgeons seem to have a strong preference to avoid a stoma, under the 
assumption that it will have negative consequences on quality of life.2, 
3 However, an anastomosis bears the risk of anastomotic leakage, which 
may cause re-operations, prolonged hospital stay, morbidity, mortality 
and possibly a worse oncological outcome.4-6 Furthermore, functional 
outcome after a low anastomosis, especially in combination with 
radiotherapy or chemoradiation can also lead to an impaired quality of 
life.7, 8 Additionally, a defunctioning stoma has been proven to diminish 
the sequelae of anastomotic leakage.9 Anastomotic leakage will not 
occur when an anastomosis is avoided, e.g. when an end-colostomy 
is constructed. On the other hand, stomas may also have their own 
significant mid-to long-term morbidity and complications after reversal 
of the stoma have been reported.10-14
 In order to inform and involve patients in preoperative clinical 
decision-making, surgeons need information on outcomes of different 
treatment options. The aim of this study is to describe the short-term 
and one-year outcomes of different surgical treatment options for mid 
and high rectal cancer patients. 
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 Methods
Study population
We explored short term and one-year outcomes of all consecutive 
patients who underwent surgical resection for primary rectal cancer 
between the 1st of January 2009 and 31st of June 2011 in 7 different 
hospitals in the Netherlands. Surgical resection was performed 
according total mesorectal excision. In patients with high tumors 
surgical resection was performed five centimeters below the tumor 
with the mesorectum optionally left in situ. Patients with a tumor less 
than 5 cm from the anal verge, patients undergoing abdominoperineal 
resection, and patients with a T4 tumor were excluded, because these 
patients represent subgroups with other surgical approaches and 
subsequent different expected outcomes.
Outcomes
We extracted information on the following patient and tumor 
characteristics: age, gender, ASA-classification, co-morbidity, abdominal 
surgical history, preoperative tumor complications, tumor stage, additive 
resections and distance of tumor to the anal verge. 
 Short term endpoints, defined as endpoints until 30 days after 
initial surgery, were postoperative complications, re-interventions, 
prolonged hospital stay and postoperative mortality. Complications 
were defined as all postoperative complications, both non-surgical and 
surgical, during hospital admission; anastomotic leakage was defined 
as clinically relevant anastomotic leak requiring re-intervention, both 
radiological and surgical; re-interventions were defined as all additional 
procedures, both radiological and surgical, performed for the treatment 
of all postoperative complications; surgical re-interventions were 
laparotomy or laparoscopy; a prolonged hospital stay was defined as 
hospital stay longer than 14 days; postoperative mortality was defined as 
in-hospital mortality or within 30 days after primary surgery. 
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One-year outcomes were unplanned readmissions and re-interventions 
after initial admission, presence of a stoma and mortality within one-
year. From patients with a defunctioning stoma or end-colostomy, we 
extracted data on whether a second surgery was performed to restore 
bowel continuity; post-operative complications and hospital stay of this 
procedure were also analyzed. 
Analyses
The study population was divided in three groups according to 
their received surgical treatment: anastomosis, anastomosis with 
defunctioning stoma, or end-colostomy. Whether or not patients with 
an end-colostomy had a resection of the rectal stump was not taken 
into account. During the study period, patients switched between these 
groups, because of re-interventions for complications, or because of 
elective secondarily stoma reversal. Patient and tumor characteristics 
and short-term postoperative outcomes were described in relation to 
the initial received surgical treatment. For analysis of the one-year 
outcomes, analyses groups were defined according their anastomosis/
stoma status after first hospital admission. A Chi-squared analysis was 
performed to investigate differences in short-term outcomes.
 For one-year outcomes the differences in readmission rate, re-
intervention rate and 1-year mortality were statically tested. Statistical 
significance was defined as p<0.05. All statistical analyses were 
performed in PASW Statistics, Rel. 18.0.2009. 
 Results
During the period of January 2009 to June 2011, 843 consecutive patients 
underwent surgical resection for primary rectal cancer in the 7 
participating hospitals. A total of 455 patients were excluded (14 
urgent resections, 386 patients with low rectum tumors (<5 cm) and/
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or undergoing an abdominoperineal resection,), and 45 patients with 
a T4 tumor). Patients with unknown anastomosis/stoma status were 
excluded as well (n=10). After selection according the eligibility criteria, 
388 patients undergoing low anterior resection for rectal cancer were 
included in this study.
Short-term outcomes
Table 1 shows patient and treatment characteristics according to initial 
surgical treatment; seventy-two patients (19%) received a primary 
anastomosis 214 patients (55%) had an anastomosis with defunctioning 
stoma, and 102 patients (27%) an end-colostomy. Patients with an end-
colostomy were significantly older; and a higher ASA-classification 
when compared to both other groups; patients with an anastomosis 
had significantly higher tumors; patients with a defunctioning stoma 
less often had distant metastases and more often received neoadjuvant 
chemo-radiation therapy. Fifty-nine per cent of the defunctioning 
stomas concerned loop ileostomies; 41% were loop transversostomies
Postoperative complications
Table 2 shows the short-term outcomes after initial surgery. One third 
of all patients developed a postoperative complication; regardless of the 
type of surgery. Anastomotic leakage rates were 10% (n=7) in patients 
with an anastomosis; and 7% (n=14) in patients with defunctioning 
stoma (not statistically significant; p=0.46). 
Re-interventions and hospital stay
There were no statistically significant differences between the 
three treatment groups in overall percentage of re-interventions. In 
patients with an anastomosis with or without a defunctioning stoma, 
re-interventions were mainly surgical, while patients with an end-
colostomy mainly underwent re-interventions for stoma or wound 
management. Eighty-six per cent of patients, in which anastomotic 
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leakage occurred, needed a surgical re-intervention. This percentage 
was similar for patients with and without a defunctioning stoma 
(respectively 6 out of 7 and 12 out of 14). Patients with a defunctioning 
stoma and patients with an end-colostomy had a trend towards a longer 
hospital stay, although this difference was not statistically significant.
Postoperative Mortality
Postoperative 30-day or in-hospital mortality rates were low: 0% in 
patients with an anastomosis, 1% in patients with an anastomosis with a 
defunctioning stoma and 2% in patients with an end-colostomy. 
One-year outcomes 
Unplanned readmissions
Table 3 shows the follow up outcome of the three groups as situated after 
first hospital admission: 62 patients (16%) with an anastomosis; 209 
patients (54%) with an anastomosis with a defunctioning stoma, and 117 
patients (30%) with an end-colostomy. Patients with a defunctioning 
stoma had a readmission rate of 18%, mostly due to (late) anastomotic 
leakage. Patients with an end-colostomy had a readmission rate of 
17%, mostly due to stoma-related problems. Patients with a primary 
anastomosis had a significantly lower readmission rate than both 
other groups. Only one patient of the primary anastomosis group was 
readmitted because of anastomotic leakage, and two patients for other 
reasons. 
Re-interventions 
Both patients with a defunctioning stoma and patients with an 
end-colostomy had a 12% re-intervention rate. In patients with a 
defunctioning stoma, 5% underwent a surgical re-intervention in which 
the anastomosis was disconnected and an end-colostomy was created. 
Five percent of patients underwent a radiological drainage. Revision 
of the stoma was the most frequent re-intervention in patients with 
RISKS, BENEFITS, AND DECISION-MAKING48   Chapter 2PART  I:   
an end-colostomy (7%). Also, in this group, 5% of patients underwent 
radiological drainage of an abscess. Only one patient with a primary 
anastomosis underwent a re-intervention because of anastomotic 
leakage. In this patient, the anastomosis was disconnected and an end-
colostomy was created. 
Stoma reversal
In the majority of patients with a defunctioning stoma, bowel continuity 
was restored with a second surgery. In 22% of patients, the stoma was 
not reversed after one-year. The overall complication rate after stoma 
closure was 24%; and the anastomotic leakage rate was 4% (Table 3). In 
patients with an end-colostomy, 5% underwent a second surgery to 
restore bowel continuity. In half of the patients, this secondary surgery 
was performed within 6 months after the initial surgery. The mean 
hospital stay after stoma reversal was 6 days for both defunctioning 
stomas and end-colostomies. There were no deaths after stoma closure.
Mortality
One-year mortality rate was the highest in patients with an end-
colostomy; twenty-two patients (19%) in this group died. None of these 
deaths were surgery-related; all deaths were due to progression of the 
underlying disease or due to other diseases. 
Switching between treatment groups
Due to changes in anastomosis/stoma status, patients switched between 
the three different treatment groups during the entire study period 
(Figure 1). After initial surgery, 19% of patients had a primary anastomosis, 
55% had an anastomosis with defunctioning stoma, and 27% of patients 
had an end-colostomy. The percentage of patients with an end-
colostomy increased with 30% (n=31). This increase consisted mainly 
of patients with initially a defunctioning stoma, in which anastomotic 
leakage occurred. Due to unplanned re-interventions and elective stoma 
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reversal, eventually 60% of all patients had an anastomosis, 6% had an 
anastomosis with defunctioning stoma, and 34% had an end-colostomy.
 Discussion
Overview of findings
The present study described short-term and one-year outcomes of 
different treatment strategies in rectal cancer surgery. Although 
patients with a defunctioning stoma had a somewhat lower risk for 
short-term anastomotic leakage, they had a high risk for unplanned 
readmissions and re-interventions, mostly due to late anastomotic 
leakage. Furthermore, these patients had an additional high risk for 
postoperative complications after restoration of bowel continuity, 
including anastomotic leakage. In contrast, the one-year outcomes of 
patients with an anastomosis were surprisingly good. Although both 
groups were not completely comparable, the large difference in one-year 
outcomes could hardly all be due to lower tumors and a higher use of 
chemoradiotherapy in patients with a defunctioning stoma. 
 One expects that patients with an end-colostomy would have 
worse post-operative outcomes, since these patients were significantly 
older, and had a higher ASA-classification. Interestingly, these patients 
had a similar risk for postoperative complications, and even a lower 
risk for invasive re-interventions. This is probably an over-estimation 
of the actual risk associated with an end-colostomy. On the long-term 
however, end-colostomies were associated with stoma problems or pelvic 
abscesses causing unplanned readmissions.
Comparison with other studies
The value of a defunctioning stoma to diminish the consequences of 
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anastomotic leakage has been the subject of debate for a long time. 
Earlier randomized studies showed fewer anastomotic leaks and 
reoperations after low anterior resection with a defunctioning stoma.9,15, 
16 A considerable amount of retrospective studies also describes the 
beneficial effect of a defunctioning stoma on direct postoperative 
anastomotic leakage rates.6, 17-19 On the other hand, there studies that 
support the notion that the routine use of a defunctioning stoma in low 
anterior resection is not advisable. Fielding et al. observed that there was 
a higher leakage rate in patients with a defunctioning stoma (18% versus 
7%); Enker et al and Matthiessen et al showed that a defunctioning 
stoma did not reduce the incidence of anastomotic leakage in patients 
undergoing low or ultralow anterior resection.20, 21 Furthermore, a study 
from our own group showed that while during the last decade there was 
an increase in the use of defunctioning stomas, anastomotic leakage 
rates remained similar.22 
 Previous studies described the long-term stoma problems 
of both defunctioning stomas and end-colostomies.13,14 A study of 
163 patients undergoing an extended Hartmann resection, showed 
pelvic abscesses in 30% of patients, diagnosed on a median of 35 days 
postoperative (range 7-434).23 Two studies reported on high readmission 
rates of patients with defunctioning stomas.24, 25  In contrast with our 
findings, patients were mostly readmitted because of dehydration. This 
might be related to the fact that in our study, 41% of the defunctioning 
stomas were transversostomies, which are known to have less 
dehydration problems than ileostomies.26 Den Dulk et al described the 
policy of stoma formation in patients entered in the Dutch TME-trial 
for rectal cancer, and found that 20% of the stomas were never reversed, 
which is similar to our findings. We found a high overall morbidity 
and anastomotic leakage rate after stoma reversal, which is confirmed 
by previous publications; overall morbidity rates of 20-30% and 
anastomotic leakage rate of 2-9% after closure of defunctioning stomas 
have been reported.12, 27, 28
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Strengths and limitations
An important strength of this study is that both the short-term and 
one-year outcomes were thoroughly evaluated. As far as we are aware, 
this is the first study to take into account one-year outcomes of all three 
surgical options. In most studies and audits, only short-term results are 
reported. As shown in this study, ongoing changes in outcome occur 
during the first year after surgery for rectal cancer due to complications 
and stoma reversal. Therefore, it is critical to take these long term 
outcomes into account when different surgical strategies are considered.  
 However, some limitations deserve mentioning. There was a 
possibility of a selection bias, as we randomly selected seven different 
hospitals. However, comparison of our cohort to the national data of 
the Dutch Surgical Colorectal Audit, including all patients undergoing 
surgical resection for colorectal cancer in the Netherlands, showed no 
significant differences in patient, tumor and treatment characteristics 
(data not shown).29 Moreover, due to our small sample size, the 
outcomes could not be corrected for differences in case-mix since this 
requires a large amount of cases to prevent over-fitting. A larger study 
is needed in order to provide a case-mix adjusted comparison in both 
short- and long-term outcomes between the different groups. 
Clinical implications and future research
In this study, we found favorable outcomes in patients with an 
anastomosis. These are probably caused by adequate identification 
of high-risk patients. In these patients, an end-colostomy to prevent 
short-term anastomotic leakage may be the best decision. Although an 
end-colostomy has the risk for stoma problems or pelvic abscesses on 
the long term, these are less consequential than immediate postoperative 
anastomotic leakage. Avoiding or limiting the risk for anastomotic 
leakage by routine creation of defunctioning stomas is not desirable, 
especially considering its poor one-year outcomes found in this study. 
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Scoring systems that could predict a patients’ risk for anastomotic 
leakage pre-operatively should be the focus of future studies to facilitate 
decision-making.30 Also, focusing on improvements in intraoperative 
conditions and surgical techniques rather than routine creation of 
defunctioning stomas may be the way to go. Previous studies with 
intraluminal devices showed good results in preventing anastomotic 
leakage and a multicenter randomized study is currently being 
performed.31 
 While the decision whether or not to make an anastomosis 
remains difficult, patients’ preferences concerning the risk of morbidity 
and mortality of anastomotic leakage versus the consequences of stomas 
should be taken into account. This consideration requires thorough 
preoperative counselling.  
 Conclusion
Although a large proportion of patients received defunctioning stomas, 
these were associated with significant long-term morbidity including 
late anastomotic leakage. An end-colostomy may be a safe alternative to 
prevent anastomotic leakage, but long-term problems may also occur. 
Favorable outcomes in patients with an anastomosis are probably caused 
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Figure 1. Changes in distribution of patients undergoing resection for mid and 
high rectal cancer according to stoma or anastomosis construction during the 
first year.
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Chapter 3: 
PREOPERATIVE RISK INFORMATION AND 
PATIENT INVOLVEMENT IN SURGICAL
TREATMENT FOR RECTAL AND SIGMOID
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 Abstract 
Introduction: Surgery for rectal and sigmoid cancer is an exemplary 
setting for investigating preoperative information provision and Shared 
Decision Making (SDM), since the decision consists of a trade-off  
between the pros and cons of different treatment options. The aim 
of this study was to explore surgeons’ opinion on the preoperative 
information that should be given to rectal and sigmoid cancer patients 
and to evaluate what is actually communicated. Seconds, we assessed 
surgeons’ attitudes towards Shared Decision Making and compared these 
with patient involvement. 
Methods: A questionnaire was sent to Dutch surgeons with an interest 
in gastroenterology. Preoperative consultations were recorded. A check 
list coded the information surgeons communicated to the patients. The 
OPTION-scale was used to measure patient involvement.
Results: Questionnaires were sent to 240 surgeons and 103 (43%) 
responded. They requested information on anastomotic leakage, its 
consequences, benefits and risks of a defunctioning stoma and impact 
of a stoma on quality of life necessary preoperative information. In 
practice, patients were inconsistently informed of these items. Most 
participants agreed to using SDM in their consultations. In practice, 
most patients were offered only one treatment option and little SDM was 
seen. The mean OPTION-score was low. (7/100)
Conclusions: The information given to patients with rectal and sigmoid 
cancer to decide on which surgical option they would prefer is 
insufficient. Information should be given on all treatment options with 
their complications and outcome before any decision is made. 
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 Introduction
In recent years, the concept of Shared Decision Making (SDM) has 
gained widespread appeal to both clinicians and patients.1, 2 In SDM, 
clinicians and patients make decisions together using the best available 
evidence.2  SDM is considered especially important for patients who 
present with a serious illness such as cancer, when the outcomes are 
uncertain, or when different treatment options are available.3 Since 
different possible outcomes (benefits and risks) of the treatment options 
may vary in their impact on the patient’s physical and psychological 
well-being, informing patients on these matters is the cornerstone of 
decision making about treatment.4
 The decision on surgical treatment for rectal and sigmoid cancer 
is a trade-off between benefit and harm, in which, besides tumour and 
patient related factors, both doctors’ and patients’ preferences play a 
role. When tumour size, stage and location allow a sphincter preserving 
resection, the surgical treatment options consist of an anastomosis, an 
anastomosis with a defunctioning stoma, or an end-colostomy. 
 Both patients and surgeons seem to have a strong preference 
to avoid a stoma, under the assumption that it will have negative 
consequences for the quality of life.5, 6 However, an anastomosis bears 
the risk of anastomotic leakage (AL), which may cause re-operation, 
prolonged hospital stay, morbidity, a possibly  worse oncological 
outcome and even mortality.7-9  
 The benefits of preventing or minimizing AL should always be 
balanced against the disadvantages of the alternatives. A defunctioning 
stoma itself carries a substantial risk of becoming permanent.10, 11 The 
morbidity and mortality of closure of a defunctioning stoma should 
also be taken into account.12 Different studies report that stomal 
complications are prevalent, seen in 25 to 50% of patients with a stoma 
after 8-10 years of follow-up.13, 14 Finally, as opposed to the negative 
influence of a stoma on quality of life, patients with a (low) anastomosis 
also have a risk for functional derangements, such as incontinence, and 
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sexual- and bladder dysfunction.15 
 In order to make this complicated decision, thorough 
preoperative information provision to patients on these possible 
outcomes seems essential before a decision is made on the preferred 
treatment option.   
 The aim of this study was first to explore gastroenterological 
surgeons’ opinion on the necessary information that should be provided 
preoperatively on treatment options, including their related benefits 
and harms and on SDM. We assessed what information surgeons 




This study consisted of a questionnaire and a clinical encounter study.
Participants
A questionnaire was distributed among all Dutch surgeons with a 
specialty in the field of colorectal surgery. The questionnaire was sent to 
all by email; a reminder was sent once. 
Moreover, all gastroenterological surgeons of a Dutch university hospital 
and four regional hospitals were asked to record their consultations with 
patients with rectal and sigmoid cancer at the outpatient clinic, between 
May 2011 and March 2012.  Patients received information required for 
each recording. The medical ethics review board agreed on patients 
giving verbal consent prior to recording.
Questionnaire 
The questionnaire first asked surgeons to indicate on a 4-point Likert-
scale (1=not important at all to 4=very important) whether they think 
patients with rectal and sigmoid cancer should be informed about 
various treatment outcomes of the different options (table 2). Next, 
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surgeons were asked to indicate on a 4-points Likert scale (1=not at all 
to 4 =very much) whether they are familiar with SDM, whether they 
agree with using SDM in their consultations and whether they think they 
perform SDM. Also, they were asked to indicate on a 4-points Likert 
scale (1=not at all to 4=very much) to which extend they experiences 
each of 8 barriers in practice for implementing SDM .16, 17 Barriers 
were subdivided into two groups; practical and attitudinal (see Figure 
1). Finally, surgeons were asked about their years of experience in their 
specialization, their institution, and their numbers of rectal and sigmoid 
cancer cases they see monthly. 
Clinical encounter study
Surgeons were equipped with a digital tape recorder and instructions 
regarding its use. All newly diagnosed patients with rectal and sigmoid 
cancer with an appointment at the outpatient clinic were eligible for 
participation. Patients with metastases at the time of primary surgery 
or resections for multiple synchronous colorectal tumors were excluded 
because these represent subgroups of patients with other treatment 
perspectives and different expected outcomes. We excluded patients 
with lowest 5 cm rectal cancer, since in these patients there is only one 
option, which is a permanent stoma. 
 We developed a checklist with a team of members with 
various backgrounds in medicine, psychology, epidemiology, and 
communication research to code what information on treatment options, 
and their related benefits and harms surgeons communicated with their 
patients. The checklist was based on the literature and following Knops 
et al. 1
 We coded first whether general information on the procedure 
and general risks of the procedure were communicated with a patient. 
Second, we coded whether all therapeutic options (anastomosis with 
and without a defunctioning stoma and an end-colostomy) with their 
benefits and side-effects, were explicitly presented to a patient. All items 
were scored as ‘mentioned’ or ‘not mentioned’. See for items Table 3.
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For each consultation, the patient’s sex, age, and tumour location were 
registered.  
Analyzes
Two raters (HS, MK) independently analyzed and coded the same ten 
audiotapes. Disagreement was solved in consensus.  As substantial 
agreement between raters was found (Cohen’s Kappa = 0.94) the 
remaining tapes were coded individually. 
Spearman correlations were computed to assess the association between 
the extent to which surgeons experience barriers for using SDM and 
their age and years of experience. Likert-scale answers were analyzed in 
two groups (1-2 versus 3-4). 
 To evaluate patient involvement in the decision about the 
type of surgery, we used the OPTION-scale. 18 This one-dimensional 
scale assesses the magnitude of SDM use during the physician–patient 
consultation by identifying twelve SDM-specific behaviors that 
clinicians can adopt to promote patients’ active participation in decision 
making. The items are coded on a five-point scale, where “0” indicates 
the nonperformance of a behavior and “4” indicates the performance of 
a behavior at high competency.   The overall patient involvement score is 
a value between 0 and 100, with a higher score indicating more frequent 
and/or higher quality display of clinicians’ behaviors to involve patients 
in the treatment decision. 




A total of 103 surgeons responded to the questionnaire (response 
rate 43%). An average of ten minutes was needed to complete it. 
Characteristics of participants are shown in Table 1. The clinical 
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encounter study consisted of 32 recorded consultations conducted by 
11 different gastroenterological surgeons in five different hospitals. The 
characteristics of participating surgeons, hospitals, and patients are also 
shown in Table 1.
Preoperative information
Surgeons’ opinion on necessary preoperative information
Nearly all respondents considered information on the risk of 
anastomotic leakage after creation of an anastomosis to be essential 
(99%). Also, the risk of re-operation and the risk of a stoma due 
to leakage were regarded as important elements of pre-operative 
counseling, as 93% of respondents considering both items. The majority 
of the respondents (77%) indicated that the risk of a fecal incontinence 
should always be mentioned. The risk of death due to leakage should 
be mentioned “often” according to 27% of the respondents, and always 
according to 57%. The other results are shown in Table 2. The 11 
surgeons of whom the consultations were audio-taped did not differ in 
their opinions when compared to the other respondents. 
Information giving in practice
None of the information items were mentioned consistently in every 
consultation (Table 3). Information on the surgical procedure was 
provided during most of the consultations; information on laparoscopic 
or open surgery (81%); removal of (a part of ) the bowel (72%); 
remaining of two bowel ends (75%); and duration of hospital stay (69%) 
were mentioned often. 
 Three of ten items regarding general risks of surgery were 
mentioned occasionally: postoperative hemorrhage (47%), wound 
infection (41%) and pneumonia (13%).  Other risk-items were not 
mentioned. 
 A primary anastomosis was the surgical treatment option 
mentioned most often (84%). The advantages of the avoidance of a 
stoma were mentioned to most of these patients (70%).  Also, the risk of 
PART  I: RISKS, BENEFITS, AND DECISION-MAKING Chapter 3 68   
anastomotic leakage was mentioned in almost all of these patients (93%). 
The surgical treatment ‘anastomosis with defunctioning stoma’ 
was mentioned to 16 patients (53%).  Most of these patients (88%) 
were informed on the fact that this is a safer option than a primary 
anastomosis. The advantage of diminishing the consequences of 
anastomotic leakage was mentioned to half of the patients (44%). A 
prolonged hospital stay and death due to anastomotic leakage were 
mentioned in one consultation (6%). Information on re-operation or 
the risk of a stoma due to leakage were never mentioned. It was often 
(88%) mentioned that the defunctioning stoma initially is meant to be 
temporary. The necessity of a second surgery was mentioned to only 
three (19%) patients. The risks of complications after second surgery 
and potential stomal complications were never mentioned. 
 An end-colostomy as a surgical treatment option was mentioned 
to seven (22%) patients. The fact that there is no risk of anastomotic 
leakage was mentioned to one of these seven patients (14%). The 
advantage that fecal incontinence problems are avoided with this option 
was mentioned to three of seven patients (43%). None of these patients 
were informed on potential stomal complications.
Shared Decision Making
Surgeons’ attitude towards SDM
Forty-one percent of all surgeons indicated to be at least quite a 
bit familiar with the concept of SDM. Ninety-one percent of the 
respondents stated to agree at least quite a bit with using SDM in 
their consultations. At least 37% of the surgeons indicated to use SDM 
quite a bit in their preoperative consultations with rectal and sigmoid 
cancer patients. Surgeons perceived various barriers for implementing 
SDM in their practice and they did not agree to one or more most 
important barriers (Figure 1).  The most often cited barrier was the lack 
of applicability due to perceiving patients as not capable of making 
treatment decisions (42%). No correlation was found between the extent 
to which surgeons experienced barriers for using SDM and their age or 
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number of years of experience.
Patient involvement in practice
In more than half (55%) of the consultations, only one treatment 
option was presented to the patient. In one third (34%), the patient was 
presented with two options. In three consultations (9%) the patient 
was informed about three options.  The mean OPTION-score of all 
consultations was 7 points (range 2-25) on a 0-100 scale. 
 Discussion
This study had a dual objective. Firstly, the aim was first to investigate 
surgeons’ attitude towards essential information provision and SDM. 
The second aim was to assess what information surgeons actually 
communicated preoperatively and to what extent they involved patients 
in decision making.
 Although surgeons considered most information on risks and 
alternative treatment options to be essential for decision making, this 
was not reflected in practice. We found that patients were insufficiently 
and inconsistently informed about risks of surgery, alternative treatment 
options, and their pros and cons, when compared to what surgeons 
considered as necessary preoperative information. Whilst information 
was usually given on the surgical treatment option ‘an anastomosis’, 
its procedure and the most important risks of surgery such as AL and 
alternative treatment options were often not mentioned at all. In this 
way, the patient is directed towards one specific treatment option, which 
will often be the one preferred by the surgeon.  
 This phenomenon has been previously described in some 
studies investigating information provision to patients undergoing 
surgical treatment.19 Knops et al. studied preoperative information 
communicated to patients about to undergo surgery for an abdominal 
aneurysm.20 They found that although surgeons informed patients 
about the disorder and about their individual prognosis, alternative 
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treatment options were not discussed. Also, Vohra et al. investigated 
whether patients were informed about risks of cardiac surgery and found 
that the surgeons did not discuss more then one treatment option with 
patients.21 
 Some limitations of this study deserve attention. We audio taped 
only the first consultation of patients with rectal and sigmoid cancer 
at the outpatient clinic. Therefore, we may have missed information 
that was discussed during other related consultations. It is however 
important to realize, that most decision-making takes place in the 
first encounter with the surgeon, and at that point all information on 
treatment options and risks should have been addressed at least to some 
extent.31 Also, participating surgeons knew they were audio taped, which 
may have biased their information provision and caused them to be 
more comprehensive that they would otherwise be. This would lead to 
an overestimation of the information provided. However, research has 
shown that this effect fades within minutes as the surgeon returns to his 
or hers standard routine.32 
 Last, the inclusion of both rectal and sigmoid cancer patients 
may have caused a somewhat heterogeneous study population, and 
subgroups of patients could differ in their treatment perspectives or 
outcomes. We excluded patients with lowest 5 cm rectal cancer to 
attempt to create a homogeneous cohort with respect to preoperative 
sphincter dysfunction. Considerable leakage rates in patients with 
high rectal and sigmoid cancer have been described. 33 We therefore 
considered items related to anastomotic leakage, and the need for 
defunctioning stomas relevant in all subgroups.
 Surgeons agreed on the importance of providing information 
but seemingly did not manage to do so during the first visit. The major 
aim of the first visit is possibly not to address the large amount of 
issues required for SDM in rectal and sigmoid cancer surgery, but to 
gain the trust of the patient and family and to establish a relationship 
of truth-telling. Ideally, the moment of decision making would be 
postponed from the first consultation to a second consultation at 
which the patient has had the time to consider his/her options. Details 
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of consent, including complications and alternative procedures can 
then be discussed in the meantime by nurses or other members of the 
surgical team. In practice however, there may not be the possibility 
to have a second preoperative encounter, due to economic reasons. A 
less expensive solution would be to inform the patient before the first 
consultation with the surgeon, for example with printed or web-based 
materials describing the therapeutic options and their most important 
pros and cons, or with decision aids with additional values clarification 
methods. 34 These decision aids may support patients in forming 
preferences for the different options and treatment outcomes. Decision 
aids have proven to be particularly useful in situations of equipoise, 
where the surgeon is comfortable in providing the patient a choice 
between two medically equivalent options.35 The use of multimedia-
based programs such as film or animation may be of additional 
value.36-38 Patient navigation by nurse practitioners or physician 
assistants is another suggested approach to addressing informational 
needs and facilitate the decision making process. 39
 These methods serve to empower the patient for a consultation 
with the surgeon, in which the information can subsequently be 
individualized to that patient. 
In our study, the majority of the responding surgeons had a positive 
attitude towards SDM. The discrepancy between the positive attitude 
and the absence of putting SDM into clinical practice suggests that 
barriers exist, which was confirmed in our study. We found that almost 
half of the surgeons experienced the fact that patients are unable to 
participate in decision making in rectal and sigmoid cancer treatment 
as a barrier for SDM. This inability could be related to the patients’ 
characteristics, as well as to the difficulty of the clinical situation, which 
both have been nominated as important barriers for SDM by physicians 
in multiple settings.22-26
 Stiggelbout et al provide some simple steps for clinicians, to 
enable the process of SDM.2   The first and most important step is 
creating awareness that there are different options, that there is no best 
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choice and that a decision has to be made. If patients are not made aware 
that more than one option is available, they will not realize a decision 
is to be made. Next, the benefits and harms of each option need to be 
laid out as well as their respective probabilities. Exact probabilities 
are not always needed, but in most preference-sensitive decisions the 
patient will need numbers to be able to weigh the pros and cons. 3 
Finally, patients’ ideas, concerns, and expectations about the options 
should be elicited, and the patient should be supported in the process of 
deliberation. With these steps, patients will not only receive all necessary 
information on their possible treatments, but will become more involved 
in deciding about their treatment, and will experience a more tailored 
treatment decision making process.
 
 Conclusion 
The information necessary for patients with rectal and sigmoid cancer 
in order to decide on which surgical option they prefer seems far from 
complete in clinical practice. We recommend giving information on 
at least all treatment options and their most important consequences 
before decision making takes place. Alternative methods to enhance 
information giving such as improved printed materials, multimedia-
based programs, or patient navigators should be explored and developed.
Figure 1.  Perceived barriers for implementing Shared Decision Making into 
their own practice (n=85).
Percentage of participants is displayed which stated to agree at least quite a bit on the different items.
Patient is not capable
Patients’ decisional role preference
My lack of familiarity with SDM
My lack of access to services
Leaving responsibility to patients
Time pressure
My lack of motivation
Challenge to my autonomy
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AN INCREASING USE OF DEFUNCTIONING 
STOMAS AFTER LOW ANTERIOR RESECTION 
FOR RECTAL CANCER. IS THIS THE WAY TO GO?
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 Abstract 
Introduction: The last decade there has been an increased awareness of 
the problem of anastomotic leakage after low anterior resection for rectal 
cancer, which may have led to more defunctioning stomas. In this study, 
current use of defunctioning stomas was assessed and compared to the 
use of defunctioning stomas at the time of the TME-trial together with 
associated outcomes. 
Methods: Eligible patients with rectal cancer undergoing low anterior 
resection were selected from the Dutch Surgical Colorectal Audit 
(DSCA, n=988).Similar patients were selected from the TME-trial 
(n=891). The percentages of patients with a defunctioning stoma, 
anastomotic leakage and postoperative mortality rates were studied. 
Multivariable models were used to study possible confounding on the 
outcomes.
Results: At the time of the TME-trial, 57% of patients received a 
defunctioning stoma. At the time of the DSCA, 70% of all patients 
received a defunctioning stoma (p<0.001). Anastomotic leakage rates 
were similar (11.4% and 12.1%; p=0.640). The postoperative mortality 
rate differed (3.9% in the TME-trial vs. 1.1% in the DSCA; p<0.001), but 
was not associated with a more frequent use of a stoma (OR 1.80, 95% CI 
0.91-3.58).  
Conclusion: In current surgical practice, 70% of patients undergoing 
LAR for rectal cancer receives a defunctioning stomas. This percentage 
seems increased when compared to data from the TME-trial. Clinically 
relevant anastomotic leakage rates remained similar. Therefore, current 
routine use of defunctioning stomas should be questioned.  
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 Introduction
During the past decades the strategy for surgery in rectal cancer has 
changed considerably. With the introduction of total mesorectal excision 
(TME) there has been an improvement in surgical techniques which 
enabled low anterior resections where previously abdominoperineal 
resections were performed1-3. Concurrently, radio-chemotherapy has 
become a more common neo-adjuvant therapy4,5. However, with an 
increasing number of primary anastomoses there are more patients 
at risk for possible anastomotic leakage6,7. The last decade, the 
problem of anastomotic leakage has been widely addressed in multiple 
symposia and many publications8. Leakage rates from 3% to >20% 
leading to substantial postoperative morbidity and mortality have been 
reported9-12. Anastomotic leaks may also be associated with decreased 
local control and long term survival13-17. Many solutions have been 
sought to prevent or diminish anastomotic leakage and its sequelae, such 
as mechanical bowel preparation, drains and intra-luminal devices. The 
only strategy that has proven to be effective is the use of a defunctioning 
stoma18. Matthiessen et al showed that patients with a defunctioning 
stoma have a risk of 10.3% compared to 28% in the group with no stoma. 
The outcome of this study combined with an increasing awareness of the 
problem of anastomotic leakage could have led to a change in surgical 
strategy and a more routinely use of a defunctioning stoma after low 
anterior resection (LAR) for rectal cancer.  The purpose of this study 
was to investigate current use of defunctioning stomas in patients 
undergoing LAR for rectal cancer by using data from the Dutch Surgical 
Colorectal Audit. We assessed whether there has been an increase 
in the use of defunctioning stomas in the last decade. Furthermore, 
postoperative outcomes were analysed. 
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 Methods
Patients
All surgically treated patients from the DSCA in 2010 were included. 
The DSCA is a national audit including patients with colorectal cancer 
in the Netherlands in which all hospitals participate. For using data from 
the DSCA, no ethical approval or informed consent was required under 
Dutch law. On a national and hospital level, data are annually checked 
for completeness and accuracy with the independent data registration 
of the National Cancer Registry (NCR)19. The dataset shows a nearly 
100% completeness on most items, including anastomotic leakage on 
validation against the NCR. Furthermore, we analysed surgically treated 
Dutch patients with rectal cancer from the TME-trial database (January 
1996 until December 1999). This randomised multicentre trial assessed 
TME surgery with or without preoperative 5×5 Gy radiotherapy.
Patients aged 18 years or over with clinically resectable adenocarcinoma 
of the rectum were randomly assigned to either radiotherapy followed 
by TME, or TME alone. Almost every hospital in the Netherlands 
participated.  There was no age limitation in the trial. The trial was 
approved by the medical ethics committees of all the participating 
hospitals. The trial design and the calculation of the sample size have 
been described in detail elsewhere.2
From both datasets only patients without distant metastases at time of 
surgery that underwent low anterior resection (LAR) with a primary 
anastomosis were selected for inclusion. Since emergency patients in 
the TME-trial were excluded, the same strategy was applied to patients 
from the DSCA. The decision to construct a defunctioning stoma was 
at the discretion of the surgeon. In both datasets anastomotic leakage 
was defined as clinically apparent leakage, for which a re-intervention 
(radiological or surgical) was necessary. 
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Endpoints, variables and statistical analyses
The use of a defunctioning stoma, the occurrence of anastomotic 
leakage and the 30-day/in hospital mortality were compared between 
both datasets using the chi-squared test. Patient, tumor and treatment 
characteristics were derived from the two databases. Univariable and 
multivariable logistic regression analyses were performed with the 
following variables to study their association with these outcomes: 
time-period, gender, age at time of diagnosis, distance of tumor from 
anal verge, T-stage and use of neo adjuvant treatment. For age; patients 
were divided into two age groups; younger than 75 years and 75 years 
and older. The use of neo adjuvant treatment was divided into three 
groups; none, short course radiotherapy (5x5 Gy), and long course 
radiotherapy (25x2 Gy)/chemo radiation therapy (CRT).  Postoperative 
mortality was defined as in-hospital mortality or mortality within 30 
days after surgery. All analyses were performed in STATA 10. Statistical 
significance was defined as p<0.05.
 Results
In total, 2434 patients were registered in the DSCA; 1530 patients were 
included in the TME-trial. For the analyses of this study, 988 patients 
from the DSCA and 891 patients from the TME-trial were included. 
Reasons for exclusion are shown in Figure 1. In the DSCA, 644 (26%) 
were treated with an abdominoperineal resection (APR), 370 (15%) 
with a low Hartmann’s procedure. In the TME-trial, 484 patients were 
treated with another procedure then low anterior resection, 419 patients 
(27%) underwent APR and 65 (4%) underwent a Hartmann’s procedure. 
While the APR rates remained similar, the increase in Hartmann’s 
procedure was statistically significant (p<0.01). Patient and disease 
characteristics of included patients are shown in Table 1. There were no 
differences between both groups in age, gender, and tumor stage. In 
the DSCA, three patients underwent a low anterior resection for tumor 
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located at 0 cm from the anal verge, but there was no difference in mean 
distance between datasets. The use of chemo radiation differed between 
both groups; at the time of the TME-trial no patients received this 
type of treatment since the trial randomized patients to receiving 5x5 
radiotherapy.
The use of a defunctioning stoma.
In the DSCA, 70% of all patients received a defunctioning stoma (692 of 
988). At the time of the TME-trial, in total 507 patients (57%) received a 
defunctioning stoma. This increase was statistically significant (p<0001). 
To assess possible confounders in this comparison, we performed 
a multivariable analysis. Table 2 shows the odds ratios for factors 
associated with a defunctioning stoma. The variable ‘time-period’ was 
entered into the analyses to investigate the difference in defunctioning 
stomas between the DSCA en the TME-trial. The odds for receiving a 
defunctioning stoma was 1.28 at the time of the DSCA when compared 
to the TME-trial (95% CI 1.01-1.62). There was a strong association 
between the use of chemo radiation and the use of a defunctioning 
stoma (OR 4.21 95% CI 2.73-6.48).  Also, gender, and tumor distance to 
the anal verge were independently associated with a more often creation 
of a defunctioning stoma. 
Anastomotic leakage
The clinically relevant anastomotic leakage rate was 12% (120 out of 
988 patients) in the DSCA. This was similar to the anastomotic leakage 
rate at the time of the TME-trial; clinically relevant leakage occurred 
in 102 of 981 patients (11%, p=0.60). The multivariable analyses for 
anastomotic leakage showed that time-period was still not significant 
after correcting for other factors (Table 3).  A defunctioning stoma, 
female gender, lower T-stage and higher distance from the tumor to 




The overall postoperative mortality rates was 1.1% in the DSCA; 11 out 
of 988 patients died during hospital stay or within 30 days after surgery. 
At the time of the TME-trial, postoperative mortality rates was 3.9% 
(35 out of 891 patients, p<0.001). In multivariable analysis, the DSCA-
time period remained associated with a reduced risk for postoperative 
mortality (Table 4). The decrease in postoperative mortality could 
not be attributed to the use of a defunctioning stoma; the use of a 
defunctioning stoma was not significantly associated with a lower 
risk for postoperative mortality (OR 1.81; 95% CI 0.91 – 3.58).  The 
occurrence of anastomotic leakage, age and gender were independent 
risk factors for postoperative mortality. 
 Discussion
This study assessed whether there has been an increase in the use of 
defunctioning stomas after low anterior resection for rectal cancer 
in the last decade since the TME-trial. We found that the substantial 
percentage of patients that received a defunctioning stoma at times of 
the TME-trial (57%) seemed to have further increased in recent years. In 
current surgical practice, 70% of patients receive a defunctioning stoma 
after LAR. Interestingly, clinically relevant anastomotic leakage rates 
remained similar. 
 Our study showed that nowadays almost one third of all patients 
received chemo radio therapy (CRT), which is an important change in 
the treatment of rectal cancer since the TME-trial.5  The association 
between CRT and the use of a defunctioning stoma was probably due to 
the fact that todays’ surgeons have the assumption that CRT is associated 
with the risk for anastomotic leakage. However, this is contradicted by 
a randomized controlled trial evaluating radiotherapy or CRT, as they 
found leakage rates of 7% in the CRT group, compared to 9% in the 
radiotherapy group, while the use defunctioning stomas was comparable 
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in both groups.4 The association of leakage and CRT was also not found 
in our study.  
 Possibly, the higher defunctioning stoma rate may have led 
to the lower postoperative mortality rate in the later period, as it is 
often stated that a defunctioning stoma protects from the clinical 
consequences of the anastomotic leak instead of lowering the incidence. 
Results of the multivariable analysis however did not show a significant 
relation between a more frequent use of a defunctioning stoma and 
lower postoperative mortality rates. Moreover, the percentage of 
anastomotic leakage requiring a re-intervention was similar in both 
time-periods. The substantial decrease in postoperative mortality 
rate over time could therefore be more due to general advances in 
perioperative care in the Netherlands such as better postoperative 
monitoring, better ICU facilities and quality of surgery in the latter 
period.20-25 Moreover, there has been increased specialization and 
centralization of rectal cancer surgery26 as well as more standardized 
postoperative surveillance27 for symptoms of anastomotic leakage. 
Furthermore, the higher percentage of low Hartmann’s procedures in the 
DSCA group (p<0.01) implies a more defensive strategy and a different 
patient selection. This could also be an explanation for the lower 
postoperative mortality in the DSCA group. 
Limitations
The datasets may not be completely comparable due to the differences 
in the intent and purpose and area of both groups. Therefore, some 
limitations deserve attention. First, in randomised trials, there is always 
a risk for selection bias, as older patients with more co morbidities are 
more often excluded from randomization.28-30 We had no information on 
co morbidity status of patients in the TME-trial.  Therefore, outcomes 
may have been influenced by this confounder. However, when we 
repeated our analysis selecting only patients with ASA I and II from the 
DSCA, this revealed similar results. Moreover, there was no difference 
in age between both groups, suggesting that the selection of only young 
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and vital patients in the TME-trial was limited. Second, the patient 
group in the TME-trial may have been subject to inclusion bias based 
on clinical T classification. It is very well possible that some patients 
were ineligible for resection because of a cT4 tumor, because downsizing 
options were more limited before the introduction of neoadjuvant 
chemo radiotherapy. However, in the DSCA, 83% of patients with chemo 
radiotherapy have another indication than cT4. Therefore we decided 
not to exclude these patients from our analysis.
Arguably, although we attempted to correct for the most important 
differences with multivariable analysis, the groups may not be perfectly 
comparable regarding purpose and period of treatment. However, the 
important point that needs to be addressed here is that the current 
percentage of patients in which a defunctioning stoma is constructed 
seems rather high, especially since has there has been no additional 
benefit on reducing anastomotic leakage rates when compared to the 
TME-trial.
Appropriate use of defunctioning stoma
There are obvious advantages of a defunctioning stoma, as multiple 
studies have shown that it can decrease the incidence of anastomotic 
leakage rates.6,18 Moreover, a defunctioning stoma can mitigate 
its consequences.31,32 However, there are several drawbacks to a 
defunctioning stoma that counterbalance its advantages. It is known 
that stomas can induce morbidity, hospital re-admission, discomfort, 
and prolonged hospital stay.33-36 In addition, in certain cases the stoma 
may not be closed, or closure itself can lead to significant morbidity 
and (rarely) mortality.37,38 Furthermore, even when a defunctioning 
stoma is constructed there is still is a considerable risk of anastomotic 
leakage.6,18,31,39  
 Finally, a defunctioning stoma is not free of costs.  A cost-
effectiveness analysis reviewed 70 consecutive patients undergoing 
LAR with and without a defunctioning stoma.40 It was estimated that 
to balance the extra cost of a stoma, the anastomotic leak rate for LAR 
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would have to be 16.5%. Their suggested goal was to limit the stoma rate 
to less than 10% of LARs performed to limit the costs. 
Patient selection
The previously described protective effect of a defunctioning stoma 
on the risk of anastomotic leakage could be confirmed in this study.  
However, the observed an increase in stomas did not seem to result in 
lower anastomotic leakage rates when both datasets are compared. The 
protective effect of a defunctioning stoma is probably most apparent 
in high-risk patients, while the additional benefit for the rest of the 
population is limited. The risk for anastomotic leakage of 28% which 
was found in the study from Mathiessen et al18 suggests a cohort of high-
risk patients. In these patients ,a defunctioning stoma led to a relative 
risk reduction of 60%, and an absolute risk reduction of 18% which 
implies a Number Needed to Treat of 5.5. The NNT however increases 
in low-risk patients with an a priori leakage risk of, say, 3%. In these 
patients, the 60% risk reduction of a defunctioning stoma leads to an 
absolute risk reduction of 1.8%, and a subsequent NNT of 55. Therefore, 
identification of high-risk patients is essential to guide appropriate use 
of defunctioning stomas.
 Scoring systems that could predict a patient’s risk for 
anastomotic leakage pre-operatively have been developed, but not yet 
validated in larger multi-centre series.41 Further focused research on this 
matter is warranted. While the decision whether or not to construct a 
defunctioning stoma remains difficult, patients’ preferences concerning 
the risk of morbidity and mortality of anastomotic leakage versus the 





In conclusion, while current use of defunctioning stomas has increased, 
there has been no benefit in reducing clinically relevant anastomotic 
leakage rates. The 70% defunctioning stoma rate in this study suggest 
routine use in current surgical practice which should be questioned 
since defunctioning stomas have clear disadvantages.  Identification 
high-risk patients and involvement of patient preferences in the decision 




Table 1:  patient and tumor characteristics of patients with rectal cancer undergoing low 
anterior resection.






































































Table 2: multivariable analyses for the use of a defunctioning stoma with adjustment 
for patient and tumor characteristics.




















OR (95% CI) p-value
1.0 (ref )
1.28 (1.01 - 1.62)
1.0 (ref )
1.14 (0.863 - 1.43)
1.0 (ref )
1.44 (1.17 - 1.77)
1.0 (ref )
1.13 (0.92 - 1.39)
2.06 (1.10 - 3.88)
0.92 (0.89-0.95)
1.0 (ref )
1.84 (1.47 - 2.30)
4.21 (2.73 - 6.48)
0.,41
1.28 (1.01 - 1.62)
0.4
1.14 (0.863 - 1.43)
0.001
1.44 (1.17 - 1.77)
0.06
1.13 (0.92 - 1.39)




1.28 (1.01 - 1.62)
0.4
1.14 (0.863 - 1.43)
0.001
1.44 (1.17 - 1.77)
0.06
1.13 (0.92 - 1.39)
2.06 (1.10 - 3.88)
<0.0011
<0.001
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1.33 (0.94 - 1.89)
1.0 (ref )
0.42 (0.30 – 0.57)
1.0 (ref )
1.00 (0.68 – 1.47)
1.0 (ref )
1.59 (1.16 - 2.18)
1.0 (ref )
0.98 (0.72 - 1.33)
2.29 (1.12 - 4.70)
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0.94 (0.53 - 1.65)
1.01 (0.619 - 1.65)
0.112
1.33 (0.94 - 1.89)
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0.42 (0.30 – 0.57)
0.9
1.00 (0.68 – 1.47)
0.004
1.59 (1.16 - 2.18)
0.06
0.98 (0.72 - 1.33)
2.29 (1.12 - 4.70)
<0.001
0.9
0.94 (0.53 - 1.65)
1.01 (0.619 - 1.65)
Table 4: multivariable analyses for postoperative mortality with adjustment for 
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Figure 1. Flow diagram of selected and excluded patients. 
DSCA = Dutch Surgical Colorectal Audit; TME = Total Mesorectal Excision
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Chapter 5: 
LARGE VARIATION IN THE USE OF 
DEFUNCTIONING STOMAS AFTER RECTAL 
CANCER SURGERY. A LACK OF CONSENSUS.
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 Abstract 
Introduction: The use of a defunctioning stoma in rectal cancer surgery 
is an exemplary setting to investigate clinical decision making, since 
choosing the ideal surgical treatment consists of a trade-off between 
benefits and risks. This study investigated 1a) factors associated with 
the use of defunctioning stomas, 1b) hospital variation and 2) surgeons’ 
perceptions regarding factors that determine this decision. 
Methods: Population based data from the Dutch Surgical Colorectal 
Audit (DSCA) were used. Factors for receiving a defunctioning stoma 
were analyzed with multivariate logistic regression analysis. Hospital 
variation was assessed before and after case-mix adjustment. A survey 
was performed among gastroenterological surgeons on the importance 
of factors for the decision to construct a defunctioning stoma or not.
Results: Male gender, higher BMI, lower tumors, preoperative 
radiotherapy, and treatment in a teaching or university hospital 
increased the odds for a defunctioning stoma. Unadjusted hospital 
ranged from 0 to 98%. Variation remained after case-mix adjustment 
(0-100%). There was also a large variation in factors considered 
important for the decision; almost all factors were ranked as ‘most 
important’ by at least one surgeon. 
Conclusion: There is large variation in the use of defunctioning stomas 
for patients with rectal cancer in the Netherlands, and a lack in 
uniformity of the selection criteria. These results underline the need to 




Rectal cancer surgery is an exemplary setting to investigate clinical 
decision making, since choosing the ideal surgical treatment consists 
of a trade-off between benefits and risks of different surgical treatment 
options. Constructing a defunctioning stoma has proven to mitigate the 
sequelae of anastomotic leakage, which is a serious complication causing 
re-operation, prolonged hospital stay, morbidity, a possibly  worse 
oncological outcome and even mortality. 17-9 Not all patients however 
benefit from a defunctioning stoma, as there are several drawbacks 
that counterbalance its advantages.2-5 When there is more than one 
generally accepted and equally effective treatment option, selection of 
the appropriate treatment should be informed by patient preferences.  
Previous research suggests that for many conditions treatment selection 
depends more on the physician’s recommendation than on patient 
characteristics or preferences.6 Consequently, differences in professional 
opinion may lead to variation in treatment patterns, which has been 
demonstrated for several conditions in various parts of the world.7-14
 The aim of this study was 1a) to assess whether patient, tumor, 
and hospital related factors were associated with a higher likelihood of 
receiving a defunctioning stoma 1b) to measure variation in the use of a 
defunctioning stoma across hospitals treating patients with rectal cancer; 
2) to assess surgeons’ perceptions regarding factors that determine this 
decision. 
 Methods
To investigate these research questions we performed two studies, a 
hospital practice study and a survey among surgeons treating rectal 
cancer patients.
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Hospital data study
Dataset
To assess practice variation and determinants of constructing a 
defunctioning stoma we derived data from the Dutch Surgical Colorectal 
Audit (DSCA), a prospectively collected clinical database in which over 
200 variables concerning the patient, co-morbidity, diagnostics, disease-
specific details, treatment, and outcomes are registered. The DSCA 
contains data registered by all hospitals performing colorectal cancer 
surgery in the Netherlands (n=92).15  The data set is disease-specific for 
colorectal cancer and shows a nearly 100% accordance on most items on 
validation against the National Cancer Registry (NKR) data set.14,16-18 
Patients
All patients undergoing low anterior resection for rectal cancer and 
in whom a primary anastomosis was constructed between January 1, 
2009 and December 31 2012 were evaluated. Patients with metastases 
at the time of primary surgery or resections for multiple synchronous 
colorectal tumors were excluded because these represent subgroups 
of patients with other treatment perspectives and different expected 
outcomes. 
Hospitals
Hospital-specific factors like procedural volume, type of hospital, 
and geographic region were assessed. Hospital type was categorized 
into general, teaching, or university hospital. Hospital volume was 
categorized into <25, 25–50 and >50 resections per year. Hospitals were 
categorized into four regions based on their topographic location. Each 
region comprises an area covered by 15-40 hospitals.  
Surgeon survey
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To assess surgeons’ perceptions regarding factors that determine 
constructing a defunctioning stoma or not, a questionnaire was 
distributed among all Dutch surgeons with an interest in the field 
of colorectal surgery (n=232). First, socio-demographic and work-
related details were assessed. Next, surgeons were offered sixteen 
patient and tumor related factors relevant for the decision to construct 
a defunctioning stoma or not after rectal resection with primary 
anastomosis. Eleven of these factors were similar to those available 
for analysis in the hospital data study.  Five additional factors were 
added: the patient’s acceptance of a stoma, patient’s acceptance of the 
risk of anastomotic leakage, lifestyle (smoking; alcohol consumption), 
perioperative factors (duration of the operation, blood loss) and 
perioperative judgment of the anastomosis. The latter three factors were 
potential risk factors for anastomotic leakage reported in literature that 
were not available in the DSCA.19-23 
 Surgeons were asked to rate all factors on a 0-100 Visual Analog 
Scale (VAS) ranging from not at all important to very important for 
their decision. Using the VAS, it was possible to calculate the relative 
importance of these factors. Descriptive analyses were used to present 
the relative importance scores of the factors.
Statistics
The association of patient, tumor and hospital factors with receiving 
a defunctioning stoma or not was assessed using a Chi-squared test. 
All variables with p<0.10 were next entered in a multivariate logistic 
regression analysis. A p-value < 0.05 was considered statistically 
significant for further case-mix adjustment.
 To compare the adjusted percentage of defunctioning stomas 
per hospital, a funnel plot was made using 95% control limits calculated 
around the mean of all hospitals.24 In the funnel plot, each hospital is 
displayed as a scatter point presenting the (adjusted) rate of patients 
receiving a defunctioning stoma by volume rate. The observed 
defunctioning stoma rate was adjusted by multiplying observed/expected 
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ratios by overall average defunctioning stoma rates of the total study 
population. Hospitals’ expected defunctioning stoma rates were obtained 
using coefficients from the multivariate logistic regression analyses. 
 Results
Hospital data study
On December 31st 2012, 92 hospitals had registered a total of 11.093 
eligible primary rectal cancer patients in de the DSCA since 2009. After 
exclusion of patients without an anastomosis (n=5.500), patients with 
synchronous tumors (n=943), and distant metastases (n=282), a total of 
4.368 patients were included in the analyses. 
 The mean percentage of patients in whom a defunctioning 
stoma was constructed was 67% (n=2945/4368).  Characteristics of 
patients with and without a defunctioning stoma are shown in Table 
1. Patients with a defunctioning stoma were slightly younger, were 
more often male, more often had an abdominal surgical history, higher 
tumor stage, more often a tumor closer to the anal verge, and more 
often preoperative radiation therapy when compared to patients with an 
anastomosis without a defunctioning stoma (p<0.10). 
 Results from the multivariate analysis are presented in Table 2. 
Age, abdominal surgical history, and tumor stage were not significant 
anymore. Male patients had higher odds of receiving a defunctioning 
stoma compared to female patients. Patients with a higher Body Mass 
Index (>30 kg/m2) were more likely to receive a defunctioning stoma. 
The OR increased with shorter distance of the tumor to the anal verge 
compared to those with a higher tumor. Patients receiving preoperative 
radiotherapy and patients receiving chemo radiation had higher odds 
of receiving a defunctioning stoma compared to patients receiving 
no preoperative radiation therapy. Patients diagnosed in teaching or 
university hospitals had higher odds of receiving a defunctioning stoma 
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compared to patients diagnosed in general hospitals. A higher hospital 
volume was associated with a lower odds of receiving a stoma. There was 
variation between regions in the odds of receiving a defunctioning stoma 
with the highest having a 3.5 higher odds than the lowest. 
 Unadjusted hospital variation was large: the two hospitals with 
the lowest percentage had a defunctioning stoma rate of 0% (n=0/6) and 
12% (5/41); the hospital with the highest percentage had a defunctioning 
stoma rate of 98% (n=41/42). 
 The obtained patient and tumor related coefficients from the 
multivariate analysis were used to perform case-mix adjustment for 
the percentage of defunctioning stomas per hospital. After case-mix 
adjustment, there still was a large variation between hospitals: the 
adjusted proportion of patients in which a defunctioning stoma was 
constructed ranged from 0 to 100% (Figure 1). 
 In the funnel plot, the adjusted proportion of patients in which 
a defunctioning stoma was constructed is depicted for each hospital by 
hospital type and hospital volume.  A large variation in percentage of 
defunctioning stomas remained within each type of hospital and within 
each volume category.  
Surgeon survey
One hundred and three replies (43%) were received from a single 
mailing of the questionnaire.
 They needed an average of ten minutes to complete it. The 
majority of the respondents were male (84%), mean age was 46 years 
(range, 33-64). The respondents had an average of 11 years of experience 
since their specialization (range, 1-30) and the majority had their 
specialty in the field of colorectal surgery (93%). Most of them were 
practicing in a teaching hospital or in a general hospital (respectively 54 
and 31%). The average number of new patients with rectal cancer that 
the respondents reported to encounter in the outpatient clinic was three 
per month (range, 1-30). 
112  Chapter 5 PART II: SURGICAL TREATMENT STRATEGIES
 Figure 2 shows VAS scores for the 16 factors, ordered by mean 
score. There was large variation in how the respondents scored the 
importance of factors in determining the construction of defunctioning 
stoma. Almost all factors were ranked as ‘most important’ by at least 
one surgeon, except for gender. ‘Preoperative complications’ was the 
factor with the highest average score (mean 78, SD 21) followed by co 
morbidity, tumor location and ASA-score. Gender was given the lowest 
value (mean 19, SD 22), followed by tumor-stage, abdominal surgical 
history, patients’ fear for anastomotic leakage and patients’ acceptance of 
a defunctioning stoma.
 Discussion
This nationwide population-based study showed that even after 
correction for differences in case-mix there was a substantial variation 
between individual hospitals and regions in the proportion of patients 
receiving a defunctioning stoma. Furthermore, although hospital type 
and volume had an effect on the odds of receiving a defunctioning 
stoma, also a large variation was observed within hospital types and 
volume categories.  Further, there was a large variation in the factors 
that were considered important by surgeons when deciding to construct 
a defunctioning stoma or not. These factors were different from those 
shown to be associated with the use of a defunctioning stoma in the 
hospital data study.
  
Comparison with other studies
Previous studies have demonstrated differences between hospitals for 
other aspects of colorectal cancer treatment. Elferink et al found that 
treatment patterns for radiation therapy in rectal cancer patients varied 
considerably between hospitals in the Netherlands. In their study, 
patients treated in a teaching or university hospital had lower odds and 
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patients treated in a high-volume hospital had higher odds of receiving 
preoperative radiotherapy. 25 A study from Kolfschoten et al found 
substantial differences between hospitals in the use of laparoscopic 
surgery for the treatment of colorectal cancer in the Netherlands, with 
percentages varying between 0 and 96%.26 That study reported no 
information on the relation between hospital type or volume and the 
use of laparoscopy. Morris et al studied the use of abdominal perineal 
excisions (APE) in hospitals in Great-Britain and found statistically 
significant variations in the odds of receiving an APE between individual 
surgeons, hospital trusts and cancer networks.27  Patients treated in 
hospitals with a lower surgical volume were significantly more likely to 
receive an APE.  No differences were found for hospital type.
Strengths and limitations
Our study has several strengths. It used a comprehensive national 
database, which reduces the risk of selection bias. Also, the combination 
of results of the hospital data study with those of the survey allowed 
us to explore possible mechanisms for the observed variation in 
defunctioning stomas between hospitals. This could never have be done 
when looking at the database alone.  
 Although much detailed information about patient and tumor 
demographics is available in the dataset of the DSCA, some limitations 
remain.  First, some potentially important data points may be missing.  
For example, detailed information on smoking, alcohol consumption, 
nutrition status, and preoperative sphincter function were not available. 
We have no reason to believe that some hospitals have disproportionate 
numbers of smoking patients or patients with a higher consumption 
of alcohol or lower nutrition status necessitating higher rates of 
defunctioning stomas. Moreover, high risk patients, according to the 
surgeons’ preoperative risk judgment, may not have been selected for a 
primary anastomosis, and therefore excluded which may have caused 
a potential selection bias. Last, although the response rate was not 
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optimal, it is comparable to prior reported surveys to professionals.28-30  
Clinical implications and future research
The results from the survey corroborated our expectations: that the 
variation in defunctioning stomas may be caused by a variation in 
surgeons’ opinion and perceptions regarding factors that are important 
for this decision. These findings suggest that there is no generally 
accepted strategy to select patients for a defunctioning stoma. Male 
gender increased the odds of a stoma in our hospital data study but 
were found to be the least important by surgeons in the survey, whereas 
ASA-score, urgency of surgery and age on the contrary were considered 
important, but did not explain the variation in stoma rates. The latter 
might be explained by confounding, with surgeons attributing their 
choice to .e.g. age or ASA-score whereas in fact it should have been 
gender. Further, the factors we added that were not available in the 
hospital dataset (lifestyle, preoperative factors, and judgment of the 
anastomosis) had mean scores of above 50, so might explain some of the 
residual variation in the hospital data study. 
 Our study did not focus on whether hospitals with higher 
defunctioning stoma rates had better outcomes. Another investigation 
performed by our study group however describes the lack of a significant 
correlation between hospitals’ percentage of defunctioning stomas and 
their anastomotic leakage rate (data to be published). Possibly, there 
are patients receiving a defunctioning stoma that would have had good 
outcomes without a stoma. In our study, nearly all hospitals constructed 
a defunctioning stoma in more than 10% of patients; the majority (80%) 
constructed a defunctioning stoma in even more than 50% of patients. 
Koperna et al performed a cost-effectiveness analysis, and estimated that 
to balance the extra cost of a stoma the anastomotic leak rate would have 
16.5%.5 A suggested benchmark following that study was a rate of less 
than 10% defunctioning stomas. The authors stated that a stoma rate of 
more than 50% has no supplementary effect on reducing anastomotic 
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leakage.37 A study from our own group showed that while during the 
last decade there was an increase in the use of defunctioning stomas, 
anastomotic leakage rates remained similar.31  These findings suggest 
that protective effect of a defunctioning stoma is most apparent in high-
risk patients, while the additional benefit for the rest of the population is 
limited. Identification of high-risk patients therefore seems essential to 
guide appropriate use of defunctioning stomas. An algorithm with which 
surgeons can select high-risk patients has been developed, but not yet 
validated in larger multi-center series.19 
 Further focused research on this matter is warranted since, 
obviously, a lack of agreement on which treatment strategy to use 
in different groups of patients, leads to differences between patients 
depending on surgeons’ perceptions. As a result, patients receive the 
care preferred by their physician, instead of making their own informed 
choice. Not all patients benefit from a defunctioning stoma, as there 
are several drawbacks that counterbalance its advantages. It is known 
that stomas can induce morbidity, hospital re-admission, discomfort, 
and prolonged hospital stay.32-35 In addition, in certain cases the stoma 
may not be closed, or closure itself can lead to significant morbidity and 
(rarely) mortality.2,3 Furthermore, even when a defunctioning stoma is 
constructed there is still is a considerable risk of anastomotic leakage.1, 
23, 36, 37  We advocate that patients’ preferences regarding the morbidity 
and mortality of anastomotic leakage versus the consequences of a 
defunctioning stoma should be taken into account preoperatively.  
 Conclusion
In conclusion, there is a considerable variation in the use of 
defunctioning stomas for patients with rectal cancer in the Netherlands. 
There is a need for uniformity of selection criteria for defunctioning 
stomas between surgeons. Future research should focus on an algorithm 
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selecting high-risk patients to guide the appropriate use defunctioning 
stomas.selecting high-risk patients to guide the appropriate use 
defunctioning stomas.selecting high-risk patients to guide the 
appropriate use defunctioning stomas.selecting high-risk patients to 
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Chapter 6: 
OPTIMAL TREATMENT STRATEGY 
IN RECTAL CANCER SURGERY; 
SHOULD WE BE COWBOYS OR CHICKENS?
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 Abstract 
Introduction: Surgeons and hospitals are increasingly accountable for 
their postoperative complication rates. This may lead to risk-averse 
treatment strategies. It is not known whether a risk-averse strategy 
leads to providing better care. The aim of this population-based study 
was to determine the association between hospitals’ strategy regarding 
defunctioning stoma construction and postoperative outcomes in rectal 
cancer surgery.
Methods: Data of the Dutch Surgical Colorectal Audit including 3104 
patients undergoing rectal cancer resection and receiving an anastomosis 
between January 2009 to July 2012 in 92 hospitals were used. Hospital 
variation in defunctioning stoma rates was calculated as an observed 
(O) versus expected (E) rate, adjusted for relevant case-mix factors. 
Anastomotic leakage and 30-day mortality rates were compared in 
hospitals with high and low tendency towards stoma construction.
Results: Seventy-six percent of all patients received a defunctioning 
stoma; 9.6% of all patients developed anastomotic leakage. Postoperative 
mortality was 1.8%. Hospitals’ adjusted proportion of defunctioning 
stomas varied from 0-100%. There was no significant correlation 
between hospitals’ adjusted stoma O/E rate and anastomotic leakage rate. 
Severe anastomotic leakage rates were similar (7.0 versus 7.1%, p=0.95) 
in hospitals with the lowest and highest stoma rates. Mild leakage and 
postoperative mortality rates were higher in hospitals with high stoma 
rates. 
Conclusion: A high tendency towards stoma construction in rectal cancer 
surgery did not result in lower overall anastomotic leakage or mortality 
rates. It seems that not a risk averse strategy, but the ability to select 
patients for stoma construction is the key towards preferable outcomes. 
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 Introduction
Surgical resection is the cornerstone of rectal cancer treatment. If 
tumour size, stage and location allow for a sphincter preserving 
resection, and bowel continuity is restored, the surgeon has to 
decide whether or not to defunction the anastomosis. This decision 
concerns the trade-off between benefit and harm. The advantage of 
a defunctioning stoma can be that it decreases the consequences of 
anastomotic leakage, and may also decrease its incidence.1;2 Anastomotic 
leakage is a serious complication causing re-operation, prolonged 
hospital stay, morbidity, mortality, and possibly worse oncological 
outcome.3-5 On the other hand a stoma has evident disadvantages; 
defunctioning stomas can induce morbidity, discomfort (decreased 
quality of life), higher costs6, longer hospitalisation7 and even mortality 
from surgery to close the stoma. 8-12 Furthermore, 80% of defunctioning 
stomas is only reversed after 4 months and 20 % is never reversed.13 
 Nowadays quality of care has become a major topic and 
surgeons and hospitals are increasingly accountable for their 
postoperative complication rates. This may lead to risk averse treatment 
strategies. Previous research suggests that differences in professional 
opinion may lead to variation in health care delivery.14-21 The threshold 
for the decision to construct a stoma to avoid the risk for anastomotic 
leakage may also vary between surgeons. Some surgeons may be more 
risk-taking or risk-averse than others.  However, the attempt to avoid or 
limit the risk for anastomotic leakage after colorectal surgery by frequent 
use of stomas is only in patients’ interest if it in fact lowers clinically 
relevant anastomotic leakage and mortality rates. 
The objective of this study was to investigate whether hospitals differ in 
their treatment strategy regarding construction of defunctioning stomas 
in rectal cancer surgery, and to assess if a hospital’s treatment strategy 
is related to its postoperative outcomes such as clinically relevant 
anastomotic leakage and mortality rates.
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 Methods
Study cohort
Data was derived from the Dutch Surgical Colorectal Audit (DSCA), 
a national quality improvement project in which over 200 variables 
concerning the patient, co-morbidity, diagnostics, disease-specific 
details, treatment, and outcomes are collected prospectively. The DSCA 
contains data registered by 92 hospitals (representing all hospitals 
performing colorectal cancer surgery in the Netherlands). Over 90% 
of all eligible patients are included. The dataset is disease-specific 
for colorectal cancer and has shown a nearly 100% concordance on 
most items upon validation against the Netherlands Cancer Registry 
dataset.22 All patients having undergone anterior resection for primary 
rectal cancer between the 1st of January 2009 and 31st of July 2012 
were evaluated. Minimal data requirements for inclusion in the analysis 
were:  information on tumour location, date of surgery, and mortality. 
Patients without an anastomosis, with metastasis at time of primary 
surgery, resections for multiple synchronous colorectal tumours, and 
patients with a tumour less than 5 cm from the anal verge were excluded, 
because these represent subgroups of patients with specific treatment 
perspectives and subsequent different expected outcomes. 
Definitions
Overall anastomotic leakage, as used in the hospital comparisons, 
was defined as ‘clinically relevant anastomotic leak requiring a 
re-intervention, either radiological (mild) or surgical (severe)’. 
Postoperative mortality was defined as ‘in-hospital mortality or all 
deaths within 30 days after primary surgery’. 
 The following casemix factors were considered: age, gender, 
ASA-classification, abdominal surgical history, tumour height, 
preoperative tumour complications, and urgency of the resection.
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 Considered treatment factors were surgical procedure 
(laparoscopic or open), and the use of neoadjuvant treatment.
 Hospitals were stratified into two categories: non-teaching 
and teaching hospitals. A teaching hospital is a hospital, which 
provides medical training to surgical residents. Procedural volume 
in rectal cancer resections was calculated for each hospital before the 
aforementioned exclusion of patients. Hospital volume was categorized 
into <25, 25–50 and >50 resections per year.  
Statistical considerations
As patient and tumour related case-mix factors may be responsible for 
a large part of the hospital variation in the number and proportion of 
patients with a defunctioning stoma, we adjusted for these differences 
by calculating the Observed/Expected (O/E) stoma rate. For this 
calculation, the observed outcome was the number of patients with 
a defunctioning stoma in a hospital and the expected outcome is the 
sum of all patients’ estimated probabilities for a defunctioning stoma. 
Patients’ probability estimates were derived from a backwards-stepwise 
multivariate logistic regression model, fitted on the data of all included 
hospitals, and using all case-mix factors mentioned above. For an 
average performing hospital, the observed outcome will be equal to the 
expected outcome, resulting in an O/E outcome ratio of 1. Hospitals that 
construct more defunctioning stomas than average have an O/E outcome 
ratio higher than 1, while this ratio is lower than 1 in hospitals with 
lower than average stoma rates.
Next, the adjusted hospitals O/E ratios for strategy (stoma use) were 
plotted against their anastomotic leakage rates.
 The relation between the hospitals’ strategy and its outcomes 
was analyzed by two methods. First, to evaluate whether stoma rates 
were related to (lower) anastomotic leakage rates on a  hospital level, a 
linear correlation was calculated using Pearson’s correlation coefficient 
R. Second, to evaluate whether a risk averse strategy (high stoma rates) 
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is related to better postoperative outcomes on a hospital level, hospitals 
were grouped into equally-sized groups based on quintiles of their case-
mix adjusted rate of defunctioning stomas. Differences between groups 
in outcomes (mild and severe anastomotic leakage and mortality rates) 
were analyzed using a chi-square test. 
 The association of patient and tumour related case-mix factors, 
hospital factors (teaching status, volume) and treatment factors ( 
neoadjuvant therapy, laparoscopic surgery) with being in the high stoma 
group was assessed with a chi-squared test and multivariate logistic 
regression analysis, considering the same case-mix factors as mentioned 
above All statistical analyses were performed in PASW Statistics, Rel. 
18.0.2009. Chicago.
 Results
Between January 1 2009 and July 31 2012, 92 hospitals registered all 
rectal cancer patients in de the DSCA. After exclusion of ineligible 
patients, a total of 3104 patients were included in the analysis. 
Characteristics of the included patients and hospitals are shown in 
Table 1.Of all patients, 67%  (n=2080) received an anastomosis with a 
defunctioning stoma. 
 In total, 302 patients (9.6%) developed anastomotic leakage. 
The majority (187 of 302, 62%) were severe leakages requiring a 
surgical reintervention. Anastomotic leakage rates were somewhat 
higher in patients with a defunctioning stoma (9.3 versus 10.4%), but 
this difference was not statistically significant (p=0.35). Fifteen of 302 
patients that developed anastomotic leakage, died during hospital stay 
or within 30 days after surgery (5%). Overall postoperative mortality 




Relevant casemix factors were selected by backward stepwise logistic 
regression analysis. Relevant factors for the proportion of defunctioning 
stomas were gender, preoperative complications, tumour location, and 
laparoscopic surgery.
 Hospitals’ unadjusted proportion of defunctioning stomas 
varied considerably: percentages ranged from 0-100% (figure 1). Figure 
2 shows the relation between the hospitals’ adjusted proportion (O/E 
ratio) of defunctioning stomas and the hospitals’ overall anastomotic 
leakage rate. Hospitals varied in anastomotic leakage rates (3-18%). 
There was a weak positive correlation between hospitals’ adjusted 
O/E stoma ratio and anastomotic leakage rates (r=0.032), this was not 
statistically significant  (p=0.76). 
Low versus high stoma rate
Eighteen hospitals with a total number of 604 patients were identified 
as the group of low stoma rates. This group had a mean percentage of 
26% of patients with a defunctioning stoma. The group of high stoma 
rates consisted of 18 hospitals, which treated 521 patients in total, had 
a 88% mean defunctioning stoma rate (Figure 3). A slight difference 
in overall anastomotic leak rates was found between groups, although 
not statistically significant (8.4 vs11.3%, p=0.11). Severe anastomotic 
leakage rates were similar in both groups; 7.1 versus 7.5% (p=0.95). Mild 
anastomotic leakage rates were significantly higher in the group with 
high stoma rates: 1.5 versus 3.8% (p<0.001). Postoperative mortality 
rates were significantly higher in the group with high stoma rates; 2.9 
versus 1.0% (P=0.02). The remaining hospitals formed a group with 
intermediate stoma rates (67%), and had outcomes in between the low 
and high stoma groups (9.7% anastomotic leakage, 1.7% mortality). 
 Table 2 shows the results of univariate and multivariate analysis 
for factors contributing to the odds of being in the group of high stoma 
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rates. The percentage of patients treated with short course radiation 
therapy (SCRT) was higher in the group with high stoma rates, as well 
as the percentage of patients treated in teaching hospitals. Also in 
multivariate analysis, these patients had higher odds of being in the 
group of high stoma rates. Urgent resections and volume were associated 
with a lower risk of being treated in a high stoma rate hospital in both 
univariate and multivariate analysis (Table 2). Other case-mix factors, as 




This study demonstrates a large hospital variation in treatment strategy 
concerning defunctioning stoma construction after surgical resection 
of rectal cancer, even after adjustment for relevant casemix factors. 
Hospitals with a low threshold for defunctioning stoma construction 
after rectal cancer resection did not have lower anastomotic leakage rates 
in comparison with hospitals with an opposite strategy. Interestingly, 
mortality and anastomotic leakage rates requiring radiological drainage 
were even higher in hospitals with a high stoma rate. The latter may 
be partly due to the slight difference in short course radiation therapy 
(SCRT) between both groups. Although a direct correlation between 
clinically apparent anastomotic leakage and neoadjuvant therapy has not 
been demonstrated,4;23-26 den Dulk et al showed SCRT to be a limiting 
factor for reversal of a (secondary) constructed stoma suggesting that it 
increases the risk for subclinical, or mild anastomotic leakage.27 
An explanation for the remarkable correlation between a risk averse 
strategy and low hospital volume or teaching status cannot be provided 
within the scope of this article. Possibly, these hospitals may use other 
selection criteria for defunctioning stomas, or treat patients with an 
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impaired condition for which could not be adjusted in this study.
Comparison with other studies
There is an on-going debate on differences in treatment approach 
despite ample data describing the direct correlation between the rate of 
both defunctioning stomas on the one hand, and anastomotic leakage 
and postoperative mortality on the other hand. The discussion focuses 
mainly on whether defunctioning stomas should be used routinely after 
low anterior resection to decrease anastomotic leakage rates. A meta-
analysis from Hüser et al1, mainly based on the results of a randomized 
controlled trial from Mathiessen et al2 clarifies the advantage of a 
defunctioning stoma on lowering anastomotic leakage rates. This is 
confirmed by a considerable amount of retrospective studies.4;28-30 On 
the contrary, a study from Fielding et al. observed a higher leakage rate 
in patients with a defunctioning stoma (18% versus 7%) and suggested 
that surgeons with an individual anastomotic leakage rate less than 5% 
do not need to create a defunctioning stoma at all. Both Enker et al, and 
Matthiessen et al. showed that a defunctioning stoma did not reduce the 
incidence of anastomotic leakage in patients undergoing low or ultralow 
anterior resection.7;31 Nevertheless, it has been agreed previously that 
there is a need for a benchmark on hospitals’ defunctioning stoma and 
anastomotic leakage rates. 
Strengths and limitations of study
We retrospectively evaluated a prospectively maintained, population-
based database to determine the association between hospitals’ strategy 
regarding defunctioning stoma construction and postoperative outcome 
in rectal cancer. It could be argued that comparing patient outcomes for 
patients with and without a stoma is not valid, because of confounding 
by indication: patients may have received a stoma because they were 
considered to be high risk patients and are therefore not comparable 
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to patients that did not receive a defunctioning stoma. This bias could 
also explain the relatively high mortality in the group with high stoma 
rates. However, in our study this bias is largely overcome by comparing 
hospitals at both ends of the spectrum (either very high or very low 
defunctioning stoma rates). Defunctioning stoma rates of 88% and 26% 
respectively, reflect a strategic approach (standard a stoma or standard 
no stoma), that is only slightly based on individual decision making 
concerning patient characteristics. It is likely that only very high risk 
patients received a stoma in both groups, and very low risk patients in 
both groups did not. For other patients, the decision was mainly based 
on the hospitals strategic approach. Therefore the method we used in 
our study resembles a “pseudorandomisation”. This is supported by the 
fact that baseline characteristics were similar for both groups in our 
study. 
 The findings of this study are very useful for clinical practice 
because they strengthen the concept that the decision of stoma 
formation after anterior rectal resection cannot be standardized but 
require a careful evaluation of  individual risk factors. Data represent 
current surgical practice at a population level, since all hospitals 
participate in the DSCA and the percentage of eligible patients registered 
is over 90%. 
 A limitation of this study is that analyses were performed at a 
hospital level, while the surgical strategy may differ between surgeons 
within a hospital. Information on a surgeons’ level is not available in the 
DSCA and individual volumes may be low, introducing more impact of 
chance variation in the analyses.  
Clinical implications 
Should we then be cowboys or chickens; if the latter does not necessarily 
result in better outcomes? The results confirm that the protective effect 
of a defunctioning stoma is probably most apparent in high-risk patients, 
while the additional benefit for the rest of the population is limited or 
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even non-existent. There have been numerous studies identifying risk 
factors for anastomotic leakage. 9-13 Dekker et al developed and tested 
the Colon Leakage Score (CLS) in which multiple risk factors were used 
to provide an objective prediction of the risk for anastomotic leakage.32 
They found that only 20% of their population could be considered as 
high risk. If we take into account the relative risk reduction of 64% that 
was found in the randomized trial of Matthiessen et al. (reduction in AL 
from 28% to 10%) for high-risk patients with lets say an a priori risk of 
anastomotic leakage of 20%, this would mean an absolute risk reduction 
of 12.8% and so  8 defunctioning stomas would have to be constructed in 
order to prevent one anastomotic leak. In contrast, for patients with an a 
priori risk of 5%, (ARR 3.2%) 31 defunctioning stomas would have to be 
created to prevent one leak.
 It should thereby kept in mind that stomas can induce 
morbidity, discomfort (quality of life), costs and even mortality. Stomal 
complications cause re-admission within two months after initial 
surgery in up to 17% of all patients, mostly due to de-hydratation9;11;33;34. 
Even when a defunctioning stoma is constructed, there is still is 
a considerable risk of (late) anastomotic leakage 2;4;35-37 It is also 
recognized that 15-30% of defunctioning stoma’s are never closed, 
resulting in a permanent stoma10;38 
 Future multicentre randomised trials are important to gain 
more evidence on the possible benefits of defunctioning stomas. 
However, in our opinion they can be only useful if they discriminate 
between high and low risk patients. Therefore, future studies should first 
focus on adequately identifying these patients, to prevent the creation of 
non-beneficial defunctioning stomas in low risk patients.
 Finally, we advocate that patients’ preferences concerning 
the risk of morbidity and mortality of anastomotic leakage versus the 
consequences of a defunctioning stoma should be taken into account 
preoperatively. This requires thorough preoperative counselling.  
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 Conclusion
In conclusion, a high tendency towards defunctioning stoma 
construction in rectal cancer surgery did not result in lower overall 
anastomotic leakage or mortality rates. The optimal treatment strategy 
can probably be found in hospitals with both low stoma rates and 
favourable postoperative outcomes. It seems that hospitals with low 
stoma rates were better in selecting high-risk patients, and that stoma 
formation in more patients does not lead to better outcomes. 
Adequate identification of high-risk patients should be focus of future 
studies to facilitate decision-making.
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Table 1. Patient, tumour and treatment characteristics of included patients. ASA: 
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Table 2: Univariate and multivariate analysis for factors contributing to being in the 




































































































































Figure 1.  Hospitals ranked by their case-mix adjusted defunctioning stoma rate. Based 
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Figure 2.  Hospitals’ adjusted defunctioning stoma rates plotted against their 
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Figure 3.  Comparison of outcomes between groups identified as low and high stoma 
rates. Results with an * are considered statistically significant (P<0.05).
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 Abstract 
Introduction:  In 2009, the nationwide Dutch Surgical Colorectal Audit 
(DSCA) was initiated by the Association of Surgeons of the Netherlands 
(ASN) to monitor, evaluate and improve colorectal cancer care. The 
DSCA is currently widely used as a blueprint for the initiation of other 
audits, coordinated by the Dutch Institute for Clinical Auditing (DICA). 
This article illustrates key elements of the DSCA and results of three 
years of auditing.
Methods: Key elements include: a leading role of the professional 
association with integration of the audit in the national quality assurance 
policy; web-based registration by medical specialists; weekly updated 
online feedback to participants; annual external data verification with 
other data sources; improvement projects. 
Results: In two years, all Dutch hospitals participated in the audit. 
Case-ascertainment was 92% in 2010 and 95% in 2011. External data 
verification by comparison with the Netherlands Cancer Registry (NCR) 
showed high concordance of data items. Within three years, guideline 
compliance for diagnostics, preoperative multidisciplinary meetings and 
standardised reporting increased; complication-, re-intervention and 
postoperative mortality rates decreased significantly. 
Discussion: The success of the DSCA is the result of effective surgical 
collaboration. The leading role of the ASN in conducting the 
audit resulted in full participation of all colorectal surgeons in the 
Netherlands. By integrating the audit into the ASNs’ quality assurance 
policy, it could be used to set national quality standards. Future 
challenges include reduction of administrative burden; expansion to a 
multidisciplinary registration;  and addition of financial information 
and patient reported outcomes to the audit data.  
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 Introduction
Several clinical audits have been initiated internationally, acknowledging 
the importance of reliable and valid quality information in health care. 
Clinical auditing has been recognised as an important tool for quality 
assessment and improvement, consequently leading to demonstrable 
improvements in patient outcome1-4 Moreover, clinical audits are 
increasingly appreciated as a source of information for research on 
evidence based medicine as they provide ‘real world’ data on patients 
often not eligible for clinical trials.5 However, the voluntary nature 
of existing audits may unintentionally lead to participation of mainly 
dedicated hospitals and underrepresentation of underperforming 
hospitals. Also, audit data are seldom transparent to other stakeholders 
involved in health care.   
 In 2009, the Dutch Surgical Colorectal Audit (DSCA) was 
initiated by the Association of Surgeons of the Netherlands (ASN) 
in collaboration with the Dutch Association for Surgical Oncology 
(NVCO), the Dutch Association for Gastrointestinal Surgery (NVGIC) 
and the Dutch Colorectal Cancer Group (DCCG). Their main goal was 
to evaluate and improve quality of care for primary colorectal cancer 
surgery in the Netherlands. 
 After one year of registration, participation in the audit had 
become a national performance indicator. Full participation of Dutch 
hospitals was realised within two years. Subsequent to this success, 
the Dutch Institute of Clinical Auditing (DICA) was founded in 2011 
with the objective to facilitate and organise the start-up of new nation-
wide audits. This article illustrates the introduction of the DSCA in the 
Netherlands by describing its main features and presenting the results of 
three years of auditing.
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 Methods
Main features of the DSCA
This section describes the organisational and structural key elements of 
the DSCA.
1. The initiator: the professional organisation of surgeons
All surgeons in the Netherlands are united in a professional 
organisation, the Association of Surgeons in the Netherlands (ASN). 
The ASN serves as a central protector of common interests of 
surgeons. Membership of the ASN is compulsory to all surgeons in the 
Netherlands. One of its main objectives is to assure that every surgical 
patient in the Netherlands receives high quality care. Furthermore, 
ASN continuously attempts to improve the quality of surgical care. The 
ASN uses different instruments to accomplish this, for example the 
development of evidence-based guidelines, surgical training programs 
and accreditation of surgeons in their surgical specialty. The initiation 
of clinical audits was necessary to facilitate the uniform measurement 
of quality of care and enhance the Association’s quality improvement 
efforts.
2. Dataset: involvement of all experts in the field
The ASN formed a scientific committee of mandated clinical experts 
in colorectal cancer care (surgeons, oncologists, pathologists, 
epidemiologists) to initiate the first clinical audit. The scientific 
committee defined performance indicators and outcome measures, 
based on pre-existing evidence based guidelines, to highlight potential 
quality concerns, identify areas that need further investigation, and 
track changes over time. The committee defined a dataset using a Delphi 
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method6. The dataset generally covers three aspects: case-mix variables 
(e.g. age, gender, co morbidity) necessary for hospital comparison; 
process variables (e.g. wait times and number of patients discussed in 
a multidisciplinary team); and outcomes of care (e.g. morbidity and 
mortality).  
3. Organizational structure
In accordance with the format of the DSCA, the Dutch Institute of 
Clinical Auditing (DICA) was founded to enhance other clinical audit 
initiatives in the Netherlands. The main goal of the DICA was to support 
other clinical audits by facilitating on legal, technical, methodological 
and logistic issues. Three new audits have been initiated since the 
introduction of the DSCA: the breast cancer audit (NBCA), the upper 
GI cancer audit (DUCA) and the lung surgery audit (DLSA). The 
organization structure of the DICA is graphically presented in Figure 1.
4. Funding
The onset of the DSCA was funded by quality improvement grants 
donated by a health care insurance company. Since 2013, hospitals pay 
a subscription fee for participating in the DSCA. The subscription costs 
are returned to the hospitals as they are enclosed in the payments of 
treating patients with colorectal cancer. Costs of the data registration 
itself are not compensated and are borne by the hospitals.
5. Online data is self-registered in a secured web form 
Each participating hospital appoints a surgeon responsible for 
(supervising) the data registration. The majority of the colorectal 
surgeons record the data themselves. The DSCA uses a generic internet 
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based program to enable data entry in a secured web environment7. 
Depending on the complexity of the patient and perioperative course, a 
number of 56 to 179 variables have to be completed; registration time is 
approximately 20 to 30 minutes per patient. Data-entry can be entered 
either throughout patient’s management or at the end of each admission. 
Data can be updated when necessary; for example when follow-up data 
is available. A third trusted party anonymises data regarding patient 
identification directly after data entry8. Definitions and helping texts 
are appointed to each variable in the dataset and are available during 
data entry. These guarantee that registration is performed uniformly. 
Also, frequently asked questions (FAQs) are available on the website and 
a front office can be contacted by data registrants for questions on both 
technical and content issues. 
6. Internal and external data verification
Data validity is achieved and verified in various ways. The surgeon 
receives direct feedback on erroneous, missing or improbable data 
items during data entry through quality control tools that are built in 
the program. Hospitals receive feedback information on the number of 
patients and completeness of the data to encourage the participants to 
correct them when needed. 
Data are annually compared with an external data registration, the 
National Cancer Registry (NCR), on completeness and accuracy.1 The 
NCR registers all newly diagnosed malignancies in the Netherlands. 
Information on patient characteristics (e.g. age, gender) tumour 
characteristics (TNM stage, localization, histology) treatment (surgical 
procedure, chemo and/or radiation therapy, laparoscopy, urgency of 
procedure) hospital of diagnosis, hospital of treatment and outcomes 
(30-day mortality, anastomotic leakage, CRM, lymph nodes), are 
collected from the medical records by specially trained registrars 
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9 months after diagnosis9,10. The NCR has an automatic linkage to 
many important and solid databases, among which the Municipal 
Administration (GBA), which allow the full enrolment of patients 
eligible for registration and notification for postoperative mortality. 
Quality of the NCR data is high; completeness is estimated to be at 
least 95%.11 The registration of the NCR is linked to the Municipal 
Administration, which by law receives notification on all patients that 
decease in the Netherlands. The quality of the data in comparison to the 
NCR is described elsewhere12.
7. Online feedback is provided on a weekly basis
Information regarding volume, performance indicators and outcomes 
of care are presented online to individual hospitals. Each participating 
hospital has access to its own secured website. Data are weekly updated. 
Results of the hospital are presented in relation to the national average 
and in relation to results of other anonymised hospitals. 
8. Outcomes are adjusted for differences in case-mix
The methods to measure quality of care are described in detail 
elsewhere.12,13 When comparing hospital outcomes differences in case-
mix must be taken into account.14 Therefore, a set of relevant case-
mix variables specific for each outcome measure is embedded in the 
database. A standardised co morbidity module was developed using 
the Delphi method with incorporation of the Charlson Co morbidity 
Index.15, 16 Case-mix adjusted hospital outcomes are presented in funnel 
plots using 95% confidence limits that vary in relation to the hospital 
volume.17 
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9. Results and targets for quality improvement are presented in an annual 
report.
An extensive national report presenting the results of the audit is 
published annually.12 This report focuses on various themes for 
improvements in the scope of recent literature. The results are presented 
in a yearly conference accessible to clinicians, patients, patient 
advocates, health insurers and policy makers, politicians. The conference 
functions as a platform for all parties to address their (common) 
interests and to discuss diverse health care topics. 
Analysis of results of the DSCA
The completeness of the data on a national level is described by the 
percentage of participating hospitals and case ascertainment for each 
audit year. Patient, tumour and treatment characteristics are shown 
separately for patients with colon and rectal cancer. Then, the results 
of performance indicators on both process and outcomes of care were 
evaluated using a Chi square trend test was used to analyse changes over 
time. Last, hospital variation for preoperative multidisciplinary team 
discussions for rectal cancer surgery are presented in a scatter plot, 
illustrating changes in variation over time.  
 Results
Dataset
From 2009 to 2011, 26,511 patients undergoing surgical resection for 
colorectal carcinoma were registered by all 92 hospitals providing 
colorectal cancer care in the Netherlands (8 university, 47 teaching 
and 37 non-teaching hospitals). The national case ascertainment 
and completeness of the data per patient record was high. Compared 
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with the data collected by the NCR, the DSCA included 80% of all 
eligible patients in 2009, 92% in 2010, and 95% in 2011. External data 
verification with the NCR showed nearly 100% completeness and high 
correspondence on almost all items of the dataset12. 
Patients 
Information on tumour localisation, date of surgery and mortality 
are minimal requirements for analysis of patient records. In total, 752 
patients (2.8%) were excluded for this reason. Hospitals that failed to 
register more than 10 patients were excluded to minimise selection bias. 
In 2009, this concerned 5 hospitals registering a total of 37 patients. 
In 2010 and 2011, none were excluded. In the results presented in 
this article, patients with multiple synchronous tumours (n=894) 
were excluded as well. A total of 24,828 patients were included in the 
analysis. Patient, tumour and treatment characteristics are shown in 
Table 1, stratified by tumour location: colon (n=17,729) and rectal 
cancer (n=7,099). Patients in both groups differ in age, prevalence 
of preoperative complications, urgency of the resection and tumour 
stage. Treatment patterns differ as well. For example, the percentage 
of diverting stomas is 4% in colon cancer surgery compared to 33% 
in rectal resections. Preoperative radiation therapy is applied in 84% 




A number of noticeable improvements on pre-defined performance 
indicators occurred since the introduction of the audit in 2009. These 
improvements concerned both processes as well as outcomes of care. 
Table 2 shows the results.  Definitions of the various variables are 
provided in table 3.
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Process 
From 2009 to 2011, the percentage of patients discussed in a 
preoperative multidisciplinary team increased significantly both in 
colon (46 to 68%, P<0.01) and rectal cancer surgery (80 to 96%, p<0.01). 
Moreover, the in-between hospital variation decreased during this time 
period (Figure 2). There was a significant increase in the implementation 
of guideline-recommended preoperative MR-imaging for rectal cancer 
surgery (80 to 83%, p<0.001), as well as an improved standard of 
pathological reporting of the circumferential resection margins (48% to 
80%, p<0.01).  
Outcomes
Postoperative morbidity, length of hospital stay and postoperative 
mortality decreased significantly from 2009 to 2011 both for colon and 
rectal cancer surgery. The incidence of any postoperative complication 
decreased from 33 to 31% (p<0.01) after colon resections and from 40 to 
38% (p<0.01) after rectal resections. The re-intervention rate decreased 
from 15 to 13% (p<0.001) after colon resections and from 17 to 14% 
(p<0.01) after rectal resections. Duration of hospital stay regressed with 
2 days (both after colon and rectal resections). Postoperative mortality 
rates (both in-hospital and 30-day mortality) decreased from 5.8 to 
4.0% (p=0.012) after colon resections and from 3.8 to 2.7% after rectal 
resections.  
 The percentage of patients with a positive circumferential 
resection margin (CRM) after rectal cancer surgery (≤1 mm distance 





This paper reports the key elements of the Dutch Surgical Colorectal 
Audit that have been crucial for its success. Quality of care regarding 
guideline compliance and clinical outcomes for colorectal cancer 
patients in the Netherlands improved significantly. 
 Numerous international audit projects leading to substantial 
improvements in quality of care have preceded the DSCA. Many 
examples of successful clinical audits have been described in detail. 2,3,18-
20 Often, the main goal of the audit is to generate valuable information 
for clinicians to receive feedback on the quality of care.
 A unique feature of the DSCA is the use of the audit data to 
support the effectuation of the national quality assurance policy of the 
surgical professional association, the ASN. There is a common need 
for evidence based, professionally supported consensus on what high 
quality care means in order to set standards of care.  Benchmarking 
hospital performances can support surgeons in determining the minimal 
requirements of the provided care. On a national level, outliers can be 
identified. The ASN initiated an independent audit committee to provide 
consultative advice to hospitals identified as negative outliers in the 
DSCA. Furthermore, the ASN can use the data for board certification 
of surgeons, accreditation of hospitals, national and local improvement 
projects and the provisioning of valid quality information for patients, 
health care insurers and policy makers.
 The engagement of colorectal surgeons to participate was 
mainly achieved by a strong plea for auditing in national meetings and 
conferences. The ASN strongly believed that for a valid measurement 
of quality of care, quality measures should be designed, registered, 
and interpreted by surgeons themselves. From the onset, the initiative 
was supported by the majority of Dutch colorectal surgeons, despite 
the investment in time and costs. One year later, participation became 
a quality indicator for the health care inspectorate, which ensured an 
almost 100% participation rate.
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The contents of the DSCA dataset as well as the pre-defined process and 
outcome measures are generally supported by colorectal surgeons in 
the Netherlands, since they are based on evidence based guidelines and 
developed by representatives of their own professional organization, who 
are experts in the field. The leading role of the professional association 
and its expert members in the design, development and conduct of the 
audit has important advantages. It produces meaningful and feasible 
quality information, valid in the face of participating surgeons. This may 
also have led to the high participation rate among colorectal surgeons 
and their tremendous efforts to enter high quality data in the registry. 
 In three years, a trend towards better performance indicator 
results was objectified. A significant reduction in postoperative 
morbidity and mortality was observed, as well as a reduced duration 
of hospital stay. Although promising, the continuation of these trends 
needs a longer period of registration to be confirmed. 
 Also, as was presented in Figure 2, the variation in guideline 
compliance between hospitals was reduced. Although, these 
improvements may have multifactorial causes, the active and integrated 
approach of the DSCA has at least resulted in increased awareness 
of surgeons for quality aspects of their practice and provided insight 
in areas of improvement. The potential of clinical registries to 
improve health care outcomes and lowering related costs was recently 
demonstrated in a study by Larsson et al. 21
 An important feature that supports the audit to function as a 
quality improvement tool, is the web based data collection system. This 
system facilitates timely registration of patients and automated feedback 
of benchmarked performance information on a weekly basis. These 
features may have contributed to the demonstrable improvements in 
quality of care presented here.
 In recent years there has been an increasing demand for 
valuable and reliable information on the performance of health care 
providers from various perspectives. The ASN aimed at developing a 
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system that responds to the exigencies of all major stakeholders in hospital care: 
patients, clinicians, managers, policy makers and insurance companies. Dutch 
surgeons have recently agreed to gradually publish publicly their hospital-specific 
audit results to provide transparency to all parties concerned. For the ASN, an 
important condition for external transparency is the validity and reliability of 
the data. This is assured by consistent quality checks on the registered data in 
the online system and the annual external validation with the National Cancer 
Registry. 
 A limitation of the DSCA concept is the administrative burden that is 
associated with data collection. The measurement of quality of care is complex, 
and requires the collection of multiple data points from different phases of the 
care process. The dataset is limited, but still entails detailed information to 
perform case-mix adjustment and in-depth analysis of observed variation in care 
processes. Structural data management support for the health care professionals 
is essential for a sustainable auditing process. Automated retrieval of data from 
electronic patient files is the logical next step. However, apart from the technical 
difficulties that have to be solved to extract data from the varying electronic 
systems in Dutch hospitals, it is essential that synoptic reporting is implemented 
in the administrative process of hospitals. Links between other databases like 
the Dutch Pathological Anatomical District Automatized Archives (PALGA) are 
being established to minimise the registration burden and to automate as much as 
possible.
 In the future, to reach full potential of the audit, information on 
outcomes of care should be linked to patient reported outcomes and financial 
information. Feedback to clinicians on patients’ satisfaction and quality of life 
enables them to improve their practice, attitude, facilities and outcomes. Cancer 
patient organizations in the Netherlands have already committed themselves to 
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 Conclusion
We demonstrated the feasibility of nationwide surgical audit programs, 
with national coverage and high case-ascertainment, accomplished in 
a relatively short period of time. The Dutch Surgical Colorectal Audit 
shows that substantial improvements can be realized within a time 
period of 3 years. Success factors include: a leading role for medical 
specialists, external data verification, weekly updated online feedback 
of benchmarked and meaningful quality information, and embedded 
in the quality assurance program of the professional association. In the 
Netherlands, this has been the recipe for the initiation of several other 
clinical audits, with a generic format consistent with the blueprint of the 
DSCA.
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Figure 1. Organisational structure of the Dutch Institute for Clinical Auditing (DICA).
DSCA: Dutch Surgical Colorectal Audit; NBCA: Nabon Breast Cancer Audit; DUCA: Dutch Upper GI Audit; 
DLSA: Dutch Lung Surgery Audit.
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Figure 2. Variation between hospitals in the percentage of patients with rectal cancer 
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MDT: Multidisciplinary Team; MRI: Magnetic Resonance Imaging; CRM: Circumferential Resection Margin * 
only for patients with a primary anastomosis.
Process
Cases discussed in preoperative MDT
Total colonoscopy
Preoperative MRI 
CRM reported in pathology rapport
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Table 3. Definitions used in the DSCA. 
Term   Definition
Hb=haemoglobin. CT=computed tomography.  TME=total mesorectal excision. CRM=circumferential 
resection margin.
Tumour perforation  Preoperative tumour perforation with clinical signs of faecal   
   peritonitis.
Abscess   Preoperative abscess formation in the intraperitoneal or   
   extraperitoneal spaces.
Ileus   Preoperatieve presence of (partial) mechanical bowel obstruction with  
   symptoms of abdominal cramping, abdominal distention, nausea,  
   vomiting or failure to pass gas or stool. 
Bleeding   Preoperative tumour related blood loss that requires an intervention  
   (transfusion, urgent operation) or leads to anemia (Hb <7 mmol/L in  
   male patients and <6.5 mmol/L in female patients).
Total colonoscopy  Preoperative visualization of the entire colon including the ascending  
   colon by colonoscopy or CT colonography.
(Low) anterior resection Rectosigmoid or rectal resection according to the TME principle with  
   anastomosis of the colon to the intra- or extraperitoneal rectum or anal  
   canal.
Multidisciplinary team A team that consists of all mentioned specialists: a surgeon, an  
   oncologist, a radiologist, a radiotherapist, and a gastroenterologist.
Urgent procedure  Non-elective colorectal resection that was required and performed  
   within 24 hours of admission.
Anastomotic leakage  Clinically relevant anastomotic leak requiring a radiological or surgical  
   reintervention.
Reintervention  An invasive (surgical, radiological or endoscopical) measure to  
   treat a complication (excluding superficial drainage abscess of a  
   wound abscess on the patient ward; introduction of a nasogastric tube;  
   a central venous catheter; or tracheostomy).
Positive CRM   A circumferential resection margin of 1 mm or less. 
Negative outlier  A hospital with a significantly worse (adjusted) outcome than the  
   population average of all hospitals in the registration.
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 Abstract 
Introduction:  When comparing mortality rates between hospitals to 
explore hospital performance, there is an important role for adjustment 
for differences in case-mix. Identifying outcome measures that are less 
influenced by differences in case-mix may be valuable. The main goal 
of this study was to explore whether hospital differences in anastomotic 
leakage (AL) and postoperative mortality are due to differences in case-
mix, or to differences in treatment factors. 
Methods: Data of the Dutch Surgical Colorectal Audit were used. Case-
mix factors and treatment related factors were identified from the 
literature, and their association with anastomotic leakage and mortality 
were analyzed with logistic regression. Hospital differences in observed  
anastomotic leakage and mortality rates; and adjusted rates based on 
the logistic regression models were shown. The reduction in hospital 
variance after was adjustment was analyzed with a Levene’s test for 
equality of variances.
Results: 17 out of 22 case-mix factors and 4 out of 11 treatment factors 
related to anastomotic leakage derived from literature were available in 
the database. Variation in observed AL rates between hospitals was large 
with a maximum rate of 17%. This variation could not be attributed to 
differences in case-mix, but more to differences in treatment factors. 
Hospital variation in observed mortality rates was significantly reduced 
after adjustment for differences in case-mix.
Discussion: Hospital variation in anastomotic leakage is relatively 
independent of differences in case-mix. In contrast to ‘postoperative 
mortality’ the observed anastomotic leakage rates of hospitals evaluated 
in our study were only slightly affected after adjustment for case-mix 
factors. Therefore, anastomotic leakage rates may be suitable as an 
outcome indicator for measurement of surgical quality of care.
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 Introduction
Nowadays there’s a growing public interest in quality of medical and 
surgical care, with an increasing urge for outcome measures that 
represent hospital performance. The outcome measure postoperative 
mortality is often used to benchmark surgical performance.1-3  When 
comparing mortality rates between hospitals, there is an important role 
for risk adjustment.4, 5 Observed variations in mortality may be caused 
by differences in patient and tumor characteristics (case-mix), and high 
risk patients may not be evenly distributed between hospitals.6 
 However, valid case-mix adjustments require a substantial 
amount of reliable data collected on a patient level. These data are rarely 
available and require a substantial registration effort. Therefore, it may 
be valuable to identify outcome measures that are less influenced by 
differences in case-mix and represent the actual differences in quality of 
care processes.
 Colorectal cancer is a significant source of mortality with 
nearly 10,000 new cases diagnosed in the Netherlands each year.7 
The cornerstone of this treatment is surgical resection. Patients 
undergoing surgical resection have a considerable risk for postoperative 
complications, which can lead to significant morbidity, mortality and 
large costs. Internationally, several quality improvement programs have 
therefore been initiated to reduce postoperative complications after 
colorectal surgery. 
 Anastomotic leakage is one of the most feared complications 
after colorectal surgery, often causing prolonged hospital stay, morbidity, 
mortality and possibly worse oncological outcomes.8 The percentage of 
patients developing anastomotic leakage depends on multiple factors. 
In literature, several elements have been identified as risk factors. 
These can be patient- or tumor-related, often referred to as case-mix, 
such as height of the anastomosis, a malnourished status, steroid 
use and male gender.9-13  Treatment related factors such as surgeons’ 
180  QUALITY ASSESSMENT OF COLORECTAL SURGERY Chapter 8 PART III:
experience, operative duration, blood loss, preoperative radiation and a 
defunctioning stoma have also demonstrated to be associated with the 
occurrence of anastomotic leakage.9-13 
The aim of this study was to explore whether hospital differences in 
anastomotic leakage rates are related to differences in case-mix.  We 
compared the role of case-mix adjustment for anastomotic leakage and 
postoperative mortality. With this objective, the following research 
questions were drawn: 
 1. Which case-mix and treatment related risk factors are 
associated with anastomotic leakage and postoperative mortality after 
colorectal surgery? 
 2. What are differences in anastomotic leakage and mortality 
rates between hospitals and are these due to differences in case-mix or 
due to differences in treatment-patterns? 
 Methods
Patients
Data was derived from the Dutch Surgical Colorectal Audit (DSCA), 
a national quality improvement project in which over 200 variables 
concerning the patient, co-morbidity, diagnostics, disease-specific 
details, treatment, and outcomes are collected prospectively. The 
DSCA contains data of patients registered by 92 hospitals (all hospitals 
performing colorectal cancer surgery). The data set is disease-specific 
for colorectal cancer and shows a nearly 100% accordance on most 
items, including anastomotic leakage on validation against the National 
Cancer Registry (NKR) data set.14 
 All patients undergoing resection for primary colorectal 
cancer between the 1st of January 2009 and 31st of December 2011 and 
registered in the DSCA before March 15th 2012 were evaluated. Minimal 
data requirements for inclusion in analyses were information on tumor 
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location, date of surgery and mortality. Patients with metastases at time 
of primary surgery and resections for multiple synchronous colorectal 
tumours were excluded, because these represent subgroups of patients 
with other treatment perspectives and subsequent different expected 
outcomes. Also, patients in which a primary end-colostomy was 
constructed were excluded form analysis.  
Risk Factors 
Since part of the dataset of the DSCA was designed with the objective of 
performing case-mix adjustment particularly for postoperative mortality, 
variables have been determined as risk factors for postoperative 
mortality in an early stage of conduction of the dataset. These factors 
were based on existing evidence on potential risk factors for mortality 
and determined by an expert panel using a Delphi method.6
 To assess whether there are additional case-mix and treatment 
related risk factors that need to be taken into account when adjusting 
for anastomotic leakage, we performed a systematic search for literature 
published between 1990 and 2012 on biomedical bibliographical 
databases Pubmed and the Cochrane Library. The search headings 
“anastomotic leak and colorectal surgery” were used in combination 
with the keyword “risk factor”. The “related articles” function was used 
to expand the search. References from the articles were also used when 
appropriate. Letters, reviews without original data, non-English language 
papers, overlapping patient populations and animal studies were 
excluded. 
 From the articles retrieved from the literature search, different 
risk factors for anastomotic leakage were selected. A distinction was 
made between patient and tumor related factors (case-mix factors) 
and treatment related factors. We selected risk factors with a statistical 
significance of p <0.05, which were analyzed with multivariate logistic 
regression.
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Outcomes
Various definitions of AL have been previously presented.15 The 
definition of anastomotic leakage in this study was ‘a clinically relevant 
anastomotic leak requiring a re-intervention’. Both radiological and 
surgical re-interventions were included.  Postoperative mortality was 
defined as ‘death during postoperative hospital stay or within 30 days 
after the date of surgery’. 
Analyses
The association of case-mix and treatment factors and both anastomotic 
leakage and mortality were tested with multivariate logistic regression 
models. Separate models were used for each outcome.
 To analyze the differences in anastomotic leakage and mortality 
between hospitals and investigate whether these were due to differences 
in case-mix or due to differences in treatment-patterns we applied 3 
different models. model 1: unadjusted (observed) variation in outcome; 
model 2: adjusted for patient (case-mix) characteristics; model 3: 
‘adjusted’ for case-mix and treatment characteristics. Adjustment was 
performed by calculating expected outcomes (E) using case-mix (model 
2) and both case-mix and treatment (model 3) coefficients from the 
regression analysis. Next, for each hospital, the observed percentage 
(O) was divided by the expected value (E) and multiplied by the overall 
mean (observed/E * mean) to obtain the adjusted percentages.
Hospital differences in anastomotic leakage and mortality rates before 
and after adjustment were plotted in a graph; a summary measure of 
the between hospital variance was given with ranges and standard 
deviations. The reduction in between center variance after adjustment 
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for (model 2) case-mix and (model 3)case-mix and treatment factors was 
analyzed with a Levene’s test for equality of variances.  A p-value <0,05 
was considered statistically significant. 
 
Furthermore, a mixed logistic regression model with hospitals as 
random effects was performed A likelihood ratio test was used to test 
whether the variance of the random effects was statistically significant 
after adjustment for case-mix and treatment factors.
Hospitals with more than 15% missing case-mix factors were excluded 
from multivariate analyses.  All statistical analyses were performed in 
PASW Statistics, Rel. 18.0.2009. Chicago: SPSS and R version 2.14.16 
 Results
On March 15th 2012, 92 hospitals (8 university, 47 teaching and 37 non-
teaching hospitals) registered a total of 25,555 eligible primary colorectal 
cancer patients with a date of surgery between January 1st 2009 and 
December 31 2011 in the DSCA. Nine hospitals had more than 15% 
missing case-mix factors in total, and were therefore excluded (n=1,460). 
After additional exclusion of patients with multiple synchronous tumors 
(n=598), distant metastases (n=2,032) and without an anastomosis 
(n=5,480), a total of 15,236 patients were included in the analysis. 
Characteristics of the included patients are shown in Table 1.
 Of all patients, 1207 patients (8%) developed anastomotic 
leakage and 525 patients (3.4%) died within 30 days or during hospital 
admission.
Risk factors
The literature search gave a total of 39 studies describing risk factors for 
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anastomotic leakage.8, 10-13, 17-49 In total, 22 case-mix factors and 11 
treatment related factors for were identified. Table 1 shows the results. 
 Case-mix factors described most frequently were gender, 
American Society of Anesthesiologists (ASA) score and location of 
the tumor and/or anastomosis. Treatment factors often described were 
blood loss/transfusion, duration of the operation and the use of a 
defunctioning stoma.
 Of the 22 case-mix factors for anastomotic leakage identified 
in literature, 17 were available in the DSCA. The database had no 
information on the factors weight loss, nutrition status, alcohol abuse, 
smoking and leukocytosis. Treatment factors were less often available; 4 
out of 11 were available in the dataset. 
The case-mix and treatment related risk factors that were found for 
anastomotic leakage in literature were similar to those that have been 
used for risk adjustment for postoperative mortality in the DSCA 
dataset.
 A multivariate analysis has been performed to investigate the 
association of case-mix and treatment factors with anastomotic leakage 
and postoperative mortality; results of the analysis are shown in table 2. 
 Individual case-mix factors predicting anastomotic leakage 
were male gender, urgency of the resection, renal disease and tumor 
location. Treatment related factors associated with anastomotic leakage 
were short preoperative radiotherapy, the absence of a defunctioning 
stoma and postoperative blood transfusion. For postoperative mortality 
the case-mix factors age, gender, ASA score, pulmonary disease, tumor 
location sigmoid, urgency of the resection were individual predicting 





Unadjusted hospital variation in anastomotic leakage rates was large: 
the hospital with the lowest percentage had an anastomotic leakage 
rate of 0% (n=0/166); the hospital with the highest percentage had 
an anastomotic leakage rate of 18% (n=12/70) (SD 0.036,, Figure 1a). 
After adjustment for case-mix, there was still a large variation between 
hospitals: the adjusted anastomotic leakage rates per hospital ranged 
from 0 to 17% (SD 0.033). The reduction in variation after adjustment 
for case-mix was not statistically significant (p=0.52). 
 The variance in anastomotic leakage rates significantly 
decreased after including treatment factors in the adjustment model 
(p<0.01). Case-mix and treatment adjusted anastomotic leakage rates 
varied from 0 to 12% (SD 0.024). 
For 60% of the hospitals (50/83), the unadjusted anastomotic leakage 
rate was similar to the case-mix adjusted anastomotic leakage rate. In 
36% of the hospitals, anastomotic leakage rates slightly in-or decreased 
with 1%, and in 4% of the hospitals with 2% (Figure 2a). 
For 75% of the hospitals (63/83), unadjusted anastomotic leakage rate 
altered after adjustment for treatment factors with at least 1%; for 32% of 
the hospitals, the unadjusted rate altered with more than 3% and for 10% 
with more than 5%. 
 Although hospital variance decreased after adjustment for case-
mix and treatment factors, there was still variability between hospitals as 
a likelihood ratio test showed that the variance of the random effects was 
statistically significant in all models. 
Postoperative mortality
Hospitals’ unadjusted mortality rates ranges from 0 to 10% (SD 0.017).
 The variance in postoperative mortality significantly decreased after 
case-mix adjustment (p<0.01) (range 0-6%, SD 0.012, Figure 1b). 
The variance in postoperative mortality rates slightly increased (range 
0-6%, SD 0.013)  after including treatment factors in the adjustment 
model, although not statistically significant (p=0.81). 
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For 84% of the hospitals (70/83), the unadjusted postoperative mortality 
rate altered after adjustment for treatment factors with at least 1%; for 
24% of the hospitals, the unadjusted rate altered with more than 3% and 
for 6% with more than 5% (Figure 2b).  
Adjustment for treatment factors had a slight effect on two hospitals 
when compared to the case-mix adjusted mortality rate. In these 
hospitals, case-mix adjusted mortality rate altered with 1% after 
adjustment for treatment factors. 
Hospital variability in postoperative mortality was still significant after 
adjustment for case-mix and treatment factors, as a likelihood ratio 
test showed that the variance of the random effects was statistically 
significant in all models.
 Discussion
The present study suggests that ‘anastomotic leakage rate’ is an outcome 
indicator for measurement of surgical quality of care that is relatively 
independent of differences in case-mix between hospitals. We found a 
large variation in anastomotic leakage rates between Dutch hospitals, 
which confirm the ability of this outcome indicator to be discriminative. 
In contrast to ‘postoperative mortality’ the observed anastomotic 
leakage rates of hospitals evaluated in our study could not be explained 
by differences in case-mix.  In addition, we found that the influence 
of treatment factors on the variation in anastomotic leakage rates was 
substantial. These findings imply that anastomotic leakage rates may be 
much more related to treatment factors and in hospital care processes, 
than to characteristics of the patient population treated in a certain 
hospital. Anastomotic leakage rates may therefore be a good reflection of 
the quality of care provided. 
Outcome measures
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Optimizing surgical outcomes can be seen as ‘the bottom line’ of what 
surgeons do, and outcome indicators have the advantage that they have 
‘face validity’ for surgeons as well as there patients. Also, measurement 
in itself may improve surgical outcomes – as suggested by the so-called 
Hawthorne effect. 4 As shown in our study, outcome indicators can 
present meaningful differences between hospitals. However, there was 
still significant variability in both anastomotic leakage and mortality 
rates, after adjustment for case mix factors and treatment factors in 
our study. This suggests that there are other characteristics of the 
hospital, its staff and the care they deliver, that may explain the observed 
differences. Although outcomes of care are important, process and 
structure information is essential to identify which area is susceptible 
for innovation. Therefore, adopting to the Donabedian paradigm50, 
a balanced indicator set needs to include information on structures, 
processes and outcomes. 
Limitations 
The results presented in this study should be interpreted in the light of 
some important limitations. First, despite the fact that most patient-
related risk factors were available in the database of the DSCA, it lacked 
data on some important host-related factors, such as smoking, alcohol 
consumption, nutrition status and preoperative leukocytosis. Although 
unlikely, it is possible that a strong case-mix adjustment model for AL 
could have been made when exactly those four missing factors would 
have been available from the data set. Also, high risk patients according 
to the surgeons’ preoperative risk judgment or patients with impaired 
continence at baseline may not have been selected for a primary 
anastomosis, and therefore excluded which may have caused a potential 
selection bias. It is not exactly clear how these differences in patient 
selection might affect the between hospital comparisons. Moreover, due 
to a lack of clear agreements on definitions, the factors we used may not 
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have been identical to the ones we found in literature. 
Although we found that case-mix adjustment does not seem to play a 
large role when comparing hospitals’ anastomotic leakage rates, there 
are some limitations of using it as an outcome indicator that deserve 
mentioning. It may unintentionally lead to the perverse incentive of 
aiming for the lowest possible anastomotic leakage rate by constructing 
more end-colostomies or defunctioning stomas. This defensive attitude 
would not immediately contribute to a higher quality of care, as a 
surgeon or clinic that has zero AL rates at the cost of constructing 
defunctioning stomas or end-colostomies in all patients will not be 
regarded as the best practice. Obviously, anastomotic leakage rates are 
only calculated over patients in whom an anastomosis has been created.  
Therefore hospitals, with lower rates of patients with anastomoses could 
automatically have better scores, without immediately better quality 
of care, as the stoma itself may cause morbidity, lead to a higher need 
for readmissions51, 52 and may be associated with morbidity at the 
time of surgical removal of the stoma.53 In reality, there is probably 
an optimum percentage of defunctioning stoma’s and end-colostomies 
to be created, and AL rates should always be seen in the light of these 
percentages. However, the exact optimum is unclear and it may vary 
between different surgeons or clinics. Auditing programs like the DSCA 
may help to clarify in what range this optimum should be. A composite 
quality measure might be a solution, that is a metric which includes 
whether or not AL occurred, creation of a defunctioning stoma or end-
colostomy, readmissions or mortality. Patient reported outcomes are of 
additive value in this context. The choice between an anastomosis with 
or without a defunctioning stoma or an end-colostomy can and should 
always be influenced by patient preferences.
Improvement of outcomes 
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When anastomotic leakage is used in hospital comparisons, it should be under 
the condition that practices with higher anastomotic leakage rates have the 
opportunity to improve their performance. Unfortunately, the actual cascade of 
factors resulting in anastomotic leakage still remains a ‘black box’. Our findings 
suggest that this black box consists of factors that represent multiple elements 
of the care processes taking place within a hospital. Per-operative factors, such 
as blood loss and duration of the operation have been described as important 
predictors for AL by several authors.9-13 Longer duration, more blood loss than 
anticipated, an increased anastomotic strain and limited vascular supply at the 
anastomotic sites may be a proxy of a more complicated procedure, suggesting 
that anastomotic leakage rates might be related to surgical technical skill and 
experience. Additionally, factors more related to perioperative care than to 
surgical skill, such as oliguria during the operation, are are also said to enhance 
the risk for leakage.54 
The ultimate challenge for outcome researchers is to understand the complex 
clinical mechanisms that lead to success or failure, so that the excellence of best 
practices can be transferred to all hospitals performing these procedures. 
 
Definition of AL
Comparison of AL between hospitals also requires the use of standard definitions 
and methods of measurement of AL. It has however been stated before that 
the definition of AL varies; a systematic review done by Bruce et al found 56 
separate definitions for AL used in literature.15 A valuable feature of an audit 
registration system is that it applies one definition that is used by all participants. 
In the DSCA; only clinical apparent leaks requiring re-intervention have been 
registered, and a distinction has been made between radiological and surgical 
re-intervention. Further (international) agreement on a standard definition 
that is valid and reliable, and can distinguish between clinical minor and major 
anastomotic leaks are explicitly important when using anastomotic leakage as an 
outcome indicator. 
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 Conclusion
Hospital variation in anastomotic leakage rates is relatively independent of 
differences in case-mix. Differences in treatment factors contributed more to the 
variation of anastomotic leakage rates. Further exploration of in-hospital factors 
may give insight in further improvement possibilities and understanding the 
multifactorial process that underlies anastomotic leakage. Audit programs may 
provide data for targeted visitation of clinics with bad outcomes, as well as best 
practices, aiding in identification of the most important areas for improvement.  
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Figure 1. Boxplots presenting the range in hospitals’ anastomotic leakage rates (A) and 
mortality rates (B). The unadjusted range (left), the range after adjustment for case-
mix (centre), and the range after adjustment for case-mix and treatment factors (right) 
are shown. p Values describe the statistical significance of the reduction in variance 







































































































































































































































































































































































































































































Table 1. Risk factors for AL described in literature and available patient and treatment 
characteristics of included patients in the DSCA.
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ASA= American Society of Anesthesiologists score. BMI= Body Mass Index.
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Table 2. Case-mix and treatment factors included in the multivariate logistic regres-
sion model for AL and mortality after colon and rectal carcinoma resections. Age and 
BMI were analyzed as continuous variables.
AL= anastomotic leakage; CI= confidence interval; OR= odds ratio; ASA= American Society of 
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 General discussion and future perspectives
The health care industry is undergoing  tremendous transformations. 
The extent of needed care is rapidly growing due to the aging of the 
population, and to an increase in patients with chronic diseases and 
multi-morbidity. As a consequence of rising health costs, health care 
insurers request a greater effectiveness and efficiency  in health care 
organization. Methods are being sought to ensure sustainability of health 
systems, to promote quality improvement and to shorten waiting times. 
Subsequently, the Ministry of Health and the Health Inspectorate place 
high demands on quality and safety of care provided. They request an 
increased transparency of quality of healthcare, with the ultimate goal to 
improve patient outcomes. Simultaneously, patients are becoming more 
and more empowered and knowledgeable. Internationally, initiatives 
have been taken to extend patients’ ability to choose their health care 
provider, to encourage them to make an active choice in treatment 
decisions, and to support them in the process of making these choices.1-4 
-30 
These ongoing developments inevitably affect daily surgical practice. 
Surgeons are increasingly accountable for their postoperative 
complication rates, since quality of care has become a major topic. 
Quality enhancement programs, like nation-wide clinical audits, have 
been initiated internationally. The clinical audit contains information 
of different phases of treatment, such as diagnostics, treatment and 
outcomes. Auditing has shown to provide meaningful information 
to healthcare providers, who can actually for improve their quality 
of care with the feedback on their performance compared to other 
hospitals. Frequent feedback of this information can diminish the risks 
for postoperative complications, and subsequently reduce significant 
morbidity, mortality and costs.5-7 
Simultaneously, from various angles there has been an increased demand 
for valid and reliable information on performance and outcomes of 
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care. The public reporting of outcomes may however influence surgical 
decision-making, since it may lead to a more risk-averse treatment 
strategy - with the objective to lower postoperative complication rates. 
Also, surgeons need reliable and accurate information on the risks 
and benefits of surgical treatment options to inform their patients and 
involve them in the treatment decision.
Colorectal cancer surgery is considered high-risk, since it brings along 
a relatively high number of postoperative complications. Choosing the 
ideal surgical treatment consists of a trade-off between benefits and 
risks of different surgical treatment options, which subsequently calls 
for preoperative information provision and the incorporation of patient 
preferences. Further, its high-risk nature has led to being the focus of 
several quality improvement initiatives, including the Dutch Surgical 
Colorectal Audit in the Netherlands. Therefore, colorectal cancer 
surgery is an exemplary setting to investigate postoperative risks, clinical 
decision-making and clinical auditing.
 Risks and Benefits
The results in this thesis, together with existing evidence, emphasize 
that both doctors and patients should be aware that the surgical options 
for colorectal cancer have different risks and benefits to consider. 
It is commonly known that creating an anastomosis bears the risk 
of anastomotic leakage, a serious complication contributing to one 
third of all postoperative deaths after rectal cancer surgery (chapter 1). 
Obviously, patients with an end-colostomy have no risk of anastomotic 
leakage. Although these patients run risks of stoma problems, or 
abscess complications (chapter 2), these may be less consequential than 
immediate postoperative anastomotic leakage. An end-colostomy may 
therefore be a safe short-term solution, specifically in frail patients. 
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A defunctioning stoma seems beneficial, since earlier randomized 
studies have proven that a defunctioning stoma diminishes the 
clinical consequences of anastomotic leakage 8-10, but there are 
drawbacks that argue against its use. First, a residual risk of clinically 
relevant anastomotic leakage of 7% in these patients should not be 
ignored (chapter 2). Furthermore, a defunctioning stoma reduces the 
consequences of short-term generalized anastomotic leakage, but 
does not protect from the risk for late anastomotic leakage (chapter 2); 
if anastomotic leakage is present for more than one year, secondary 
complications may occur including fistula formation, peri-ureteric 
fibrosis and infection of adjacent tissues.11,12 Moreover, a second 
surgery in which bowel continuity is restored causes an additional risk 
of complications including anastomotic leakage (chapter 2), which is 
confirmed by findings in previous research.13,14 As ongoing changes 
in outcome occur during the first year after surgery, it is essential to 
include long-term complications in the initial decision making process.
 Informing and involving the patient
The outcomes of the different treatment of reconstructive options 
in colorectal cancer surgery mentioned previously may vary in their 
impact on a patient’s physical and psychological well being. Therefore, 
involving a patient in the decision seems essential, since preferences 
towards the different options may also vary between patients.  Involving 
a patient, or performing Shared Decision Making (SDM), starts with 
thorough preoperative information provision on all relevant options, 
their consequent benefits and risks.15 Although informing a patient 
preoperatively seems self-evident in the decision making process for 
colorectal cancer surgery, at present, patients are sub optimally informed 
about risks and alternative treatment options (chapter 3). Previous 
studies have also underlined the need for improvement of the process of 
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informed consent in other domains of care.16,16,17 
Benefit
Providing risk information has additional valuable consequences; 
it encourages patients to be more aware of the limits of medical 
treatment in general; it enables the doctor to educate the patient or to 
discourage possible medical consumerism, and it may be easier for a 
doctor to maintain a constructive relationship with the patient in case a 
complication arises. Patients generally seem to appreciate to be informed 
on the risks of interventions.18 In two studies, the majority of patients 
expected to be informed of all known complications, even if the rates 
were smaller than 1%.19,20,20 
Improving patient information
An often raised argument for withholding information on surgical risks, 
is doctors’ perception that patients do not understand the concept of 
risks, and have a poor memory of the disclosed information.21 Possibly, 
the great number of issues to be addressed in colorectal cancer surgery 
acts as a complicating factor. In today’s multi-disciplinary, rapid-
throughput ambulatory care, in which patients may not even meet 
their operating surgeon until the day of the operation, such detailed 
information with comprehensive discussion of risks may be difficult to 
realize. A systematic review by Schenker et al. found a wide range of 
communication interventions that improve patient comprehension in 
informed consent, such as written information, audio-visual/multimedia 
programs, patient navigation by a nurse practitioner, extended 
discussions, and test/feedback techniques.22 These methods serve to 
empower a patient before a consultation with the surgeon in which the 
information can subsequently be individualized to that patient. Then, 
the surgeon can explore the patient’s preferences and tailor the final 
decision to what fits the patient best, which forms the basis of SDM.15 
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Improving SDM
Although in our survey Dutch surgeons underlined the necessity of SDM 
in the decision on surgical treatment for colorectal cancer, an absence 
was seen in clinical practice (chapter 3). An important reported barrier 
towards using SDM concerns surgeons’ lack of familiarity with the 
concept (chapter 3), which confirms prior research in other domains.23-26   
SDM is considered especially important for patients who present with 
a serious illness, such as colorectal cancer, or when different treatment 
options are available.3   Not only is it essential for respecting autonomy 
(enabling individuals to make reasoned informed choices), but it is also 
needed for beneficence (the balancing of benefits of treatment against 
the risks and costs) and non-maleficence (avoiding harm).27 Moreover, 
evidence suggests that patients tend to make more conservative 
decisions than their doctors, thus SDM may also reduce unwarranted 
hospital variation in treatment patterns.28 Finally, it has been suggested 
that SDM may lead to better health outcomes and lower litigation rates, 
although this evidence remains limited.29 Dutch gastroenterological 
surgeons need to be made aware of the fact that patients with colorectal 
cancer are currently not informed nor involved appropriately. As stated 
by Stiggelbout et al, and expressed in the Salzburg Statement, the 
implementation of SDM in (surgical) practice will need a culture change 
and enhanced awareness among doctors, their professional societies, and 
patients.27,30
 Patient selection
The fact that nowadays 70% of patients undergoing low anterior 
resection for rectal cancer receive a defunctioning stoma, suggests 
routine use in current surgical practice. As stomas also cause morbidity 
and discomfort to patients, and are very costly in the long run, frequent 
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use is only justifiable when it in fact lowers anastomotic leakage rates. 
The previously described protective effect of a defunctioning stoma 
on the risk of anastomotic leakage could be confirmed in this thesis 
(chapter 2, chapter 4).  However, this effect may be most apparent in high-
risk patients, while there is a limited effect in low-risk patients.  The 
beneficial effect of a defunctioning stoma was proven in a randomized 
controlled trial from Matthiessen et al. However, they studied a cohort 
with a risk of anastomotic leakage of 28%, which is high when compared 
to an average risk of anastomotic leakage of 9% found in literature 
(chapter 1). In these high-risk patients, a defunctioning stoma had a 
Number Needed to Treat of 5.5. In low-risk patients however, the NNT 
may increase to 55.  The fact that last decade’s increase in defunctioning 
stomas from 57 to 70% did not lower anastomotic leakage rates (chapter 
5) even further suggests that the effect is most apparent in high-risk 
patients only.  
Whom to select?
Adequate patient selection may therefore be the key towards better 
outcomes. Several attempts to identify possible risk factors for 
anastomotic leakage have been published in recent years (chapter 
8).  However, studies found that surgeons lack accurate prediction of 
anastomotic leakage in a single patient.31,32 The clinical judgment of 
the operating surgeon (denominated as ‘gut feeling’) seems to localize a 
subset of patients at risk of developing complications in general, whereas 
many patients with no risk factors at all may develop anastomotic 
leakage.  Apparently, the actual cascade leading to anastomotic leakage 
remains a black box. 
 Although patient-related risk factors such as height of the 
anastomosis, a malnourished status, steroid use and male gender have 
often been described as important risk factors in literature, hospital 
differences in anastomotic leakage rates could not be explained by 
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these factors (chapter 8). We found that the influence of treatment 
factors on the variation in anastomotic leakage rates was substantial. 
These findings imply that anastomotic leakage rates may be much more 
related to treatment factors and in hospital care processes, than to 
characteristics of the patient population treated in a certain hospital. An 
important note is that the database lacked data on some important host-
related factors, such as smoking, alcohol consumption, nutrition status 
and preoperative leukocytosis. 
Previous studies have also found an association of hospital- or surgeon-
related factors with the occurrence of anastomotic leakage: several 
authors have described per-operative factors, such as blood loss and 
duration of the operation as important predictors for anastomotic 
leakage. 33-37 Longer duration and more blood loss than anticipated may 
be a proxy of a more difficult procedure, suggesting that anastomotic 
leakage rates might be related to surgical technical skills. Also, an 
increased strain and limited vascular supply at the anastomotic sites 
have been considered to contribute to the pathophysiology of leakage33. 
This, again, would be more related to technical aspects than patient-
factors. The ultimate challenge for outcome researchers is to understand 
the complex clinical mechanisms that lead to success or failure, so 
that the excellence of best practices can be transferred to all hospitals 
performing these procedures. 
Hospital variation
The lack of clear guidelines on ‘whom to select’ for an anastomosis 
with or without defunctioning stoma may partly explain the variation 
we found in this thesis in the use of defunctioning stomas between 
hospitals in the Netherlands (chapter 5, chapter 6). Another possible 
explanation may be found in differences in the threshold to construct 
a defunctioning stoma (to avoid the risk of anastomotic leakage) 
between surgeons. Some surgeons may be ‘cowboys’, others ‘chickens’. 
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Interestingly, neither at a hospital level nor at a national level, 
correlation exists between a risk averse strategy (high stoma rate) and 
favourable outcomes (chapter 6). 
Feedback of information on stoma and anastomotic leakage rates, 
relative to those of peers (benchmarking), provides clinicians an insight 
in the efficiency of their current treatment strategy. Sharing knowledge 
between clinicians on the optimal selection strategy, which probably 
can be found in hospitals with both low stoma rates and favourable 
postoperative outcomes, should be promoted.
 Clinical auditing
The Dutch Surgical Colorectal Audit has proven to be a robust system to 
measure, report and enhance quality of colorectal cancer surgery in the 
Netherlands. It has led to a remarkable reduction of hospital variation 
in guideline adherence within a time period of three years only (chapter 
7). In addition, significant improvements in outcome were shown, with 
a more than 20 per cent drop in the risk of postoperative mortality and 
a 14 per cent reduction in the risk of severe postoperative morbidity 
(chapter 7). 
In the USA, a similar reduction in surgical morbidity and mortality was 
seen in the Veteran Affairs hospitals, after introduction of the National 
Surgical Quality Improvement Program (NSQIP).38 In Norway, local 
recurrence rates after rectal cancer surgery decreased from 28 to 7% 
after introduction of a national audit program.39 A systematic review 
performed by our study group confirmed the positive effect of audit and 
feedback on the quality of surgical care. 40
The surgical Hawthorne effect - measurement and feedback in itself 
may improve surgical outcomes – may underlie these trends towards 
improvement, as was also shown in a study from O’Connor et al, 
where postoperative mortality rates after CABG decreased directly 
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after surgeons were provided with feedback.41 It has also been stated 
that when feedback is accompanied with benchmark information and 
meaningful suggestions for improvement, the effect is even stronger.42
In accordance with the format of the DSCA, the Dutch Institute of 
Clinical Auditing (DICA) was founded to enhance other clinical audit 
initiatives in the Netherlands. The main goal of the DICA is to support 
other clinical audits by facilitating legal, technical, methodological 
and logistic issues. Several new audits have been initiated since the 
introduction of the DSCA: the breast cancer audit (NBCA), the upper 
GI cancer audit (DUCA), the lung surgery audit (DLSA), the aneurysm 
audit (DSAA), the carotid audit (DACI), the pancreatic cancer audit 
(DPCA), the lung radiation audit (DLRA), the cerebrovascular audit 
(CVBA),the hepatobiliary audit (DHBA), the melanoma treatment audit 
(DMTR), the european pediadric surgical audit (EPSA), and the obesity 
treatment audit (DATO).
 Outcome measures
Determining outcomes that measure and represent actual quality of care 
remains challenging. Each medical condition or population of patients 
will need their own specific set of outcome measures. Quality of care for 
procedures that are both common and relatively high-risk, as is the case 
with colorectal surgery, may be assessed using outcome measures such 
as anastomotic leakage or mortality. Postoperative mortality is the most 
often used outcome measure to benchmark surgical performance.43-45 
Case-mix adjustment
When comparing mortality rates between hospitals, there is the 
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necessity of case-mix adjustment, as some hospitals treat more severely 
ill patients than others. A study from Kolfschoten et al showed that 
case-mix significantly varies among hospitals in the Netherlands.11 
To adjust for these differences in case-mix, the DSCA has included 
baseline characteristics in its dataset, such as age, ASA-classification, 
emergency surgery, and tumour stage (chapter 8). These ‘case-mix factors’ 
however add to registration burden, which at this moment may hinder a 
sustainable auditing process.
 Therefore, future automated retrieval of data from electronic 
patient files, or structural data management support for health care 
professionals is essential. Identifying outcome measures that are 
influenced to a smaller extent by case-mix, and more by treatment and 
hospital related factors, may be useful (chapter 8). First, it will decrease 
the necessity of collecting data on case-mix factors and thereby lower 
registration burden. Second, instead of measuring variation due to 
chance or differences in case-mix, the outcome indicator discriminates 
hospitals based on their actual performance. Anastomotic leakage may 
be such an indicator. 
Structure and process outcomes
After adjustment for case-mix and treatment factors, Dutch hospitals 
still vary in both anastomotic leakage and mortality rates, (chapter 8), 
which makes both outcome measures suitable for discrimination.  This 
however also suggests that other unknown characteristics of the hospital, 
its staff and the care they deliver may contribute to the observed 
differences. Adopting the Donabedian paradigm50, a balanced indicator 
set needs to include information on structures, processes and outcomes. 
Process components refer to the interactions between the doctor and the 
patient, for example the delivery of adequate staging investigations to 
detect distant metastases. Structural factors describe the setting in which 
the care is delivered.  These structural variables, for instance, availability 
216  DISCUSSION AND APPENDICISPART IV: General discussion and future perspectives
of a high-level ICU, or on-site radiotherapy department, can be related 
to patient outcomes, especially by the influence they have on the process 
of care. 
International developments
Outcome measures can indicate meaningful differences between 
hospitals nationally, which may help identifying relevant areas of 
improvement. The next step would be to standardize health outcomes 
data globally, so that internationally doctors can learn from another and 
apply new solutions to treating patients. The International Consortium 
for Health Outcomes Measurement (ICHOM) has recently launched 
standardized sets for different conditions with the purpose to transform 
health care systems worldwide by measuring and reporting patient 
outcomes in a standardized way.46
Composite measures
Although an individual outcome or process indicator may give useful 
information for targeted quality improvement programs, a hospital may 
have a high score on one indicator, but a low score on another indicator. 
For example, a surgeon or clinic that has zero anastomotic leakage rates 
at the cost of constructing defunctioning stomas or end-colostomies in 
all patients will not be regarded as the best practice. In reality, there is 
probably an optimum percentage of defunctioning stoma’s and end-
colostomies to be created, and leakage rates should always be seen in the 
light of these percentages. 
 More comprehensive measures including both processes 
and outcomes, or the use of composite measures are needed for true 
assessment of hospital performance. Several studies have investigated the 
relation between process and outcome measures to determine whether a 
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good score on composite process measures is associated with favourable 
short-term outcomes, however with inconsistent results.47,48 Kolfschoten 
et al. investigated the validity of a composite measure, combining 
process and outcome measures using the database of the Dutch 
Surgical Colorectal Audit.49 They found that a hospital’s good score 
on the composite measures based on process indicators was correlated 
with more favourable risk-adjusted short-term outcomes. Additional 
studies with empirical testing of different composite measures to better 
understand their ability to discriminate quality of care are warranted.
Patient reported outcomes
The choice between an anastomosis with or without a defunctioning 
stoma or an end-colostomy can and should always be influenced by 
patient preferences. Therefore, patient reported outcomes measures 
(PROMs) are of additive value in this context. PROMs may provide a 
means of gaining an insight into the way patients perceive their health 
and the impact that treatments or adjustments to lifestyle have on their 
quality of life. 
Although PROM-research has proved to be highly wanted for current 
modern research on clinical outcomes50, it is important that this be 
performed in a standardized manner and based on valid, reliable and 
clinically useful measures.51Moreover, methods of communicating 
patient-reported outcomes to patients should be investigated, in 
order to increase their clinical use for the benefit of both doctors and 
patients.52 Also, response rates are an issue. Systems to increase patient 
participation in the evaluation of their health care process should be 
developed, such as web based patient logs or compensating on insurance 
fees. 
 Cancer patient organizations in the Netherlands have already 
committed themselves to collaborate in integrating PROMS in the 
clinical audits in the near future. A transparent view on true value of 
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hospitals in the Netherlands however calls for an even more integrated 
approach, as Porter et al. defined value in health care as outcomes 
relative to costs.53 The next step would be to guarantee availability of 
medical and patient reported outcomes, so that these can be weighed 
against cost. 
 Audits for patient choice
While the main aim of audit systems is to encourage doctors to improve 
the quality of care they provide, the comprehensive set of information 
can be well used to promote patients’ involvement in choosing their 
hospital or provider, and in deciding on their course of treatment.
In the Netherlands, implementation of two acts on regulated competition 
in 2006 assigned the responsibility to well-informed patients to ‘vote 
with their feet’ by selecting the healthcare providers they preferred.54,55 
Ideally, patients can use the comparative information available in the 
audit, to choosing only those healthcare providers that offer ‘best’ care. 
Unfortunately there still is a scarcity of public available meaningful 
information, even though performance indicators introduced by the 
Healthcare Inspectorate and Zichtbare Zorg Ziekenhuizen are publicly 
reported since 2003. 56 Steps towards true transparency of reliable 
audit data have however been taken. The Association of Surgeons of the 
Netherlands (ASN) has introduced a roadmap towards transparency 
in 2011, starting with public reporting of process indicators, followed 
by hospital specific outcome measures such as (case-mix adjusted) 
morbidity and mortality rates. An important condition for external 
transparency is the validity and reliability of the data in the audit, which 
is insured by the consistent quality checks on the registered data in the 
online system of the audits and the annual external validation with the 
National Cancer Registry (chapter 8).
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Audit data can also be used to enhance patient involvement in treatment 
decisions. Providers can use the information to inform patients of 
their risks of medical and surgical complications. Since the dataset 
contains 200 variables concerning the patient, co-morbidity, diagnostics, 
disease-specific details, treatment, and outcomes (chapter 7), the data 
might be used to calculate an individual patient’s risk of outcomes, 
and subsequently help patients to make informed choices and their 
treatment.57 Such risk prediction models have been developed to predict 
the outcomes of treatment in other domains of care using specific 
clinical parameters.58 A well-known model is ‘Adjuvant! Online’ for 
patients with early breast cancer, which predicts survival after surgery 
with and without adjuvant therapy.59,60 The program gives the estimated 
prognosis and expected treatment benefit in a comprehensive format 
and can help to inform patients and to involve them in decision making 
about therapeutic options.61 Similarly, patients undergoing surgery for 
colorectal cancer can be supported in the decision concerning stoma 
or anastomosis construction, by estimating their risks of unfavorable 
outcomes. The possibility of developing such a tool, by using the rich 
and detailed information from the DSCA, should be investigated. 
Furthermore, although these prediction models are increasingly used 
in the clinical consultation for breast cancer patients, little is known 
about the frequency and way in which risks are communicated in the 
consultation. Future studies should focus on the understanding of 
patients of such risk communication and the effect of its use on decision 
making and treatment choice.62 
 Conclusions
The findings in this thesis may form the basis for some important 
statements on decision-making and quality improvement in colorectal 
cancer surgery. First, Dutch surgeons should be made aware of the fact 
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that, at present, patients are not informed nor involved appropriately in 
surgical treatment decision making.  Patients’ preferences concerning 
different aspects of treatment, such as mortality, morbidity, discomfort, 
long-lasting functional effects, cure of disease, and hospital readmission 
rates should be taken into account. The risk of anastomotic leakage 
versus the consequences of a stoma seems of critical importance 
in decision-making. Methods to enhance thorough preoperative 
counselling should be developed. Surgeons can use short-term risk 
information provided by audit systems, such as the DSCA, although 
long-term outcomes need to be taken into account as well.  Furthermore, 
not a risk averse strategy per se, but optimal patient selection may be 
the key towards preferable outcomes in colorectal cancer surgery. In 
high-risk patients, an end-colostomy may be the best decision to prevent 
short-term anastomotic leakage. Routine creation of defunctioning 
stomas to limit the risk of anastomotic leakage is not desirable, 
especially considering its unfavourable one-year outcomes. The next step 
in order to improve quality of colorectal cancer care is to identify best 
practices, or better even, algorithms for adequate patient selection, and 
to share this knowledge between different doctors and hospitals.
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 Summary
The aim of this thesis was to explore several aspects of both clinical 
decision making and quality assessment in colorectal cancer surgery. 
Part one focusses on benefits and risks of treatment options, 
preoperative information provision and Shared Decision Making 
(SDM); part two investigates changes and hospital differences in surgical 
treatment strategies regarding anastomosis and stoma construction, and 
their relation with postoperative outcomes; part three describes features 
of clinical aud
Part I: Risks, benefits and decision making
 In chapter 1, a systematic search was performed for studies describing 
anastomotic leakage and the subsequent postoperative mortality 
in relation to the overall postoperative mortality after low anterior 
resection. Twenty-two studies with 10,343 patients in total were 
analyzed. The results showed a considerable overall anastomotic leakage 
rate and a large contribution of anastomotic leakage to the overall 
postoperative mortality. There was considerable variation in incidence, 
definition, and measurement of all outcomes in literature, which may 
hinder providing accurate and reliable risk information.
In chapter 2, we described both short-term postoperative and one-
year outcomes of a primary anastomosis, an anastomosis with a 
defunctioning stoma, and an end-colostomy, after surgery for rectal 
cancer. We retrospectively analyzed 388 patients in 7 different hospitals 
with one year of follow-up. In this study, patients with an anastomosis 
had a risk of 11% for anastomotic leakage. Although a defunctioning 
stoma resulted in a somewhat lower short-term anastomotic leakage rate 
(9%, not significant), we found a high (18%) unplanned readmission 
rate and a high (12%) re-intervention rate due to anastomotic leakage 
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in these patients during one year after initial surgery. Furthermore, 
we found a high risk of postoperative complications (24%), and an 
additional risk of anastomotic leakage (4%) in patients undergoing 
reversal surgery to restore bowel continuity. Although patients with 
an end-colostomy had no risk of anastomotic leakage, they had high 
readmission rates in the long term, mostly due to stoma or abscess 
complications. Furthermore, in one-fourth of all patients with a 
defunctioning stoma, bowel continuity was not restored one year after 
surgery. Due to these results, it seems critical to also take these long-
term outcomes into account when different surgical strategies are 
considered and patients are informed. 
In Chapter 3 we investigated whether patients with rectosigmoid cancer 
were adequately informed preoperatively about the options, their risks, 
and benefits,  , and whether patients were involved in the decision 
making. The opinion of Dutch gastroenterological surgeons’ regarding 
preoperative information, and their attitudes towards SDM were 
investigated by means of a questionnaire. Next, it was assessed what was 
actually communicated in practice and whether patients were involved 
in the decision by recording preoperative consultations. Surgeons 
considered most information on risks and alternative treatment options 
to be essential. However, the information provided in clinical practice 
did not meet these criteria. Alternative treatment options were often not 
mentioned at all, and patients were not involved appropriately. Despite 
the clear benefits of SDM, it is not a routine in surgical practice, and its 
implementation will need an increased awareness amongst surgeons. 
Furthermore, methods to empower the patient before a consultation 
with the surgeon need to be developed. 
Part II: surgical treatment strategies
The possibilities for sphincter saving surgery for rectal cancer have 
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increased, partly due to the improvement in surgical techniques. 
Inevitably, this has led to an increased focus on the problem of 
anastomotic leakage. The role of a defunctioning stoma to minimize 
the risks of anastomotic leakage and its sequelae has been discussed 
repeatedly. In daily practice, this decision remains difficult, as a 
defunctioning stoma also has its drawbacks and it may not be beneficial 
for all patients. With the introduction of the Dutch Surgical Colorectal 
Audit (DSCA) in the Netherlands, there has been a growing demand for 
transparency of performance. Surgeons and hospitals are increasingly 
accountable for their postoperative complication rates, which may have 
led to a change of strategy in colorectal cancer surgery and a more 
routinely use of (defunctioning) stomas after low anterior resection.
In chapter 4  we assessed whether there has been an increase in the 
use of defunctioning stomas after low anterior resection in the last 
decade (since the TME-trial). Related postoperative outcomes such as 
anastomotic leakage and mortality were analysed. We found that the 
substantial percentage of patients who received a defunctioning stoma 
at times of the TME-trial (57%) further increased in recent years; in 
current surgical practice, 70% of patients receive a defunctioning stoma 
after LAR. Interestingly, clinically relevant anastomotic leakage rates 
remained similar. Arguably, the groups may not be perfectly comparable 
regarding purpose and period of treatment. Therefore, we attempted to 
correct for the most important differences with multivariable analyses. 
Nevertheless, current percentage of patients in whom a defunctioning 
stoma is constructed seems rather high, especially since has there has 
been no additional benefit of reducing anastomotic leakage rates when 
compared to the TME-trial. The results of this study underline the 
necessity for surgeons to determine whether an increase in the use of 
defunctioning stoma is justified. It is important to focus on further 
identification high-risk patients and involvement of patient preferences 
in the decision, instead of constructing defunctioning stomas in the 
majority of patients.
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Chapter 5  had a dual objective: we first evaluated current hospital 
practice and assessed whether patient, tumour and hospital factors 
were associated with the rate of construction of defunctioning 
stomas, and whether there was variation in this rate between hospitals 
treating rectosigmoid cancer patients. Second, we surveyed all 
gastroenterological surgeons in the Netherlands to investigate their 
perceptions regarding factors that determine the construction of a 
defunctioning stoma or not. There was a considerable variation in the 
use of defunctioning stomas between hospitals. Furthermore, there was a 
lack in uniformity of selection criteria for defunctioning stomas between 
surgeons.  The results of this study underline the need to further 
improve current decision making. 
In chapter 6 we compared hospitals with regard to a risk taking or –
averse surgical strategy. We assessed whether a hospital’s defunctioning 
stoma rate was related to anastomotic leakage and mortality rates. 
Hospitals varied in their treatment strategy; even after adjustment for 
relevant case-mix factors, there are hospitals with a significantly higher 
tendency to construct a stoma. Interestingly, risk-adjusted anastomotic 
leakage and mortality rates were not lower in hospitals with a higher 
stoma rate. Probably, hospitals with low stoma rates and favourable 
outcomes were better able to select high risk patients, and stoma 
construction in more patients has no additional benefit.
Part III: quality assessment in colorectal surgery.
The DSCA was initiated by the Association of Surgeons of the 
Netherlands (NVvH) to monitor, evaluate, and improve colorectal 
cancer care in the Netherlands. Chapter 7  illustrates key elements of 
the DSCA and shows the results of three years of auditing. The article 
focuses specifically on the key elements of the audit that contributed 
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to this success and how the DSCA has a central role in the national 
quality improvement policy defined by the NVvH. The format of the 
Dutch Surgical Colorectal Audit has quickly lead to robust data with full 
national coverage: in two years, all Dutch hospitals participated in the 
audit. Data quality is high; comparison with the Dutch Cancer Registry 
shows that both datasets correspond well. Within three years, guideline 
compliance for diagnostics, preoperative multidisciplinary meetings and 
standardised reporting significantly increased; and complication-, re-
intervention and postoperative mortality rates significantly decreased. 
The combination of “how we do it” and our results so far could stimulate 
audit initiatives in other countries.
In chapter 8  we explored whether hospital differences in anastomotic 
leakage and postoperative mortality are due to differences in case-mix, 
or to differences in treatment factors. Identifying outcome measures 
that are less influenced by differences in case-mix between hospitals, 
and more by treatment- and hospital-related factors may be useful, 
since it makes such a  measure a suitable indicator for discriminating 
hospitals based on their performance. We found that hospital variation 
in anastomotic leakage was large, and, in contrast to postoperative 
mortality, relatively independent of differences in case-mix. We also 
found that treatment factors played a larger role. Likely, in-hospital 
factors are more related to anastomotic leakage than patient and tumour 
factors. Both findings make anastomotic leakage suitable as an outcome 
indicator for measurement of quality of care. 
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Samenvatting
Bij de ingewikkelde keuze van een bepaald type operatie voor 
darmkanker spelen verschillende afwegingen een rol. Niet alleen het 
type resectie maar ook eventueel continuïteitsherstel moet worden 
bepaald. De keuze bestaat uit het aanleggen van een eindstandig stoma 
en een anastomose mét of zonder ontlastend stoma.
Dit proefschrift richt zich op verschillende aspecten van deze klinische 
besluitvorming, alsmede op kwaliteitsmeting en verbetering van 
darmkankerchirurgie in Nederland. Deel I focust op de voor-en nadelen 
van de verschillende behandelingsopties, de huidige preoperatieve 
informatieverschaffing en Shared Decision Making (SDM) in de 
praktijk; deel II onderzoekt veranderingen in behandelingsstrategieën 
over de tijd, alsmede huidige verschillen tussen chirurgen en 
ziekenhuizen, in relatie tot postoperatieve uitkomsten; deel III beschrijft 
de implementatie en resultaten van ‘the Dutch Surgical Clinical 
Audit’ als een instrument voor kwaliteitsmeting en verbetering van 
darmkankerchirurgie, en onderzoekt het gebruik van naadlekkage als 
uitkomstmaat voor kwaliteit.
Deel I : Kosten, baten en klinische besluitvorming
Hoofdstuk 1 beschrijft de resultaten van een systematische review 
van de beschikbare literatuur over naadlekkage en de daardoor 
veroorzaakte postoperatieve sterfte in relatie tot de totale sterfte na een 
Laag Anterieure Resectie (LAR) vanwege rectumcarcinoom. In totaal 
werden 22 studies met 10.343 patiënten geïncludeerd. De resultaten 
toonden een gemiddeld naadlekkage percentage van 9%, alsmede een 
grote bijdrage van naadlekkage aan de totale postoperatieve sterfte. Er 
bestonden echter grote verschillen in incidentie, definitie en meting van 
de in de literatuur gerapporteerde uitkomsten. De huidige literatuur lijkt 
derhalve ongeschikt voor het geven van nauwkeurige en betrouwbare 
risico-informatie aan de patiënt.
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Hoofdstuk 2 beschrijft de korte termijn en 1-jaars uitkomsten van de 
verschillende behandelopties na sfincter-sparende rectumchirurgie 
(anastomose, anastomose met ontlastend stoma, eindstandig stoma). 
Er werden 388 patiënten geopereerd in 7 verschillende ziekenhuizen 
retrospectief onderzocht met een follow-up van 1 jaar. Eén-jaars 
uitkomsten toonden lage morbiditeit bij patiënten met een anastomose. 
Patiënten met een ontlastend stoma hadden een hoog percentage 
heropnames (18%) en reinterventies (12%), voornamelijk als gevolg 
van (late) naadlekkage. Ongeplande reinterventies bij een eindstandig 
stoma vonden veelal plaats wegens stoma-of abces problematiek. Tijdens 
follow-up was er een 25% toename van patiënten met een eindstandig 
stoma. Deze resultaten kunnen worden gebruikt in de klinische 
besluitvorming rond de behandeling en bij het preoperatief voorlichten 
van de patiënt.
In hoofdstuk 3 werd door middel van audiotapes van preoperatieve 
consulten onderzocht in hoeverre patiënten met rectosigmoid carcinoom 
adequaat werden geïnformeerd over de chirurgische mogelijkheden, 
kosten en baten, en hun betrokkenheid bij de besluitvorming. Middels 
een vragenlijst werd vervolgens de houding van Nederlandse GE-
chirurgen ten aanzien van preoperatieve informatie verschaffing en 
SDM onderzocht en vergeleken met de klinische praktijk. Ondanks 
het feit dat chirurgen de meeste informatie over risico’s en alternatieve 
behandelingsopties van essentieel belang beschouwden, werd in 
klinische praktijk informatie niet voldaan aan deze criteria. Alternatieve 
behandelingen werden vaak niet genoemd en patiënten nauwelijks 
betrokken bij de besluitvorming. Deze resultaten laten zien dat SDM 
nog niet of nauwelijks routine is in de dagelijkse chirurgische praktijk. 
Verdere bewustwording hiervan is noodzakelijk. Methoden die de rol 
van de patiënt kunnen versterken in het preoperatief gesprek dienen te 
worden onderzocht en ontwikkeld. 
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Deel II : chirurgische behandelstrategieën
De laatste tien jaar, zijn mede door verbetering van chirurgische 
technieken, de mogelijkheden voor sfinctersparende chirurgie bij 
rectumkanker aanzienlijk toegenomen. Deze ontwikkeling heeft, naast 
een kwaliteitsverbetering, onvermijdelijk geleid tot een toegenomen 
aandacht voor het probleem van naadlekkage. Multipele oplossingen 
werden in de loop der tijd onderzocht, echter van het ontlastende stoma 
werd als enige een wetenschappelijk bewezen gunstig effect gevonden, 
met name door de gevolgen van naadlekkage te beperken.
In de dagelijkse praktijk blijft deze beslissing echter moeilijk; een 
ontlastend stoma heeft ook zijn nadelen, en is derhalve niet voor alle 
patiënten een ideale oplossing. Tegelijkertijd is er vanuit meerdere 
partijen een groeiende vraag naar transparantie van zorguitkomsten. Het 
feit dat chirurgen en ziekenhuizen steeds vaker verantwoordelijk worden 
gehouden voor hun postoperatieve complicaties zou mogelijkerwijs 
geleid hebben tot veranderingen in van chirurgische strategie bij 
rectumcarcinoom. In hoofdstuk 4 werd een eventuele stijging in het 
percentage ontlastende stomata na een LAR de afgelopen tien jaar 
onderzocht, alsmede diens relatie met postoperatieve uitkomsten. Er 
bleek inderdaad een stijging in het percentage ontlastende stomata 
van 57% naar 70% te zijn geweest, echter zonder dat dit gepaard 
ging met een verwachtte daling in het percentage klinisch relevante 
naadlekkage. In de analyse werd gecorrigeerd voor de belangrijkste 
patiënt-en tumorkarakteristieken. Het huidige percentage ontlastende 
stomata suggereert een hedendaags routinematig gebruik, welke niet 
gerechtvaardigd kan worden gezien het uitblijven van een gunstig 
effect op naadlekkage percentage sinds de TME trial. Toekomstige 
onderzoeken dienen zich te focussen op het identificeren van hoog-
risico patiënten, om een verdere stijging in overbodige ontlastende 
stomata te voorkomen.
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Het doel van hoofdstuk 5 was tweeledig: ten eerste het beoordelen 
van ziekenhuisverschillen in diens percentage ontlastende stomata na 
rectumchirurgie, ten tweede het onderzoeken van de perceptie van 
Nederlandse GE-chirurgen ten aanzien van bepalende factoren in de 
aanleg van een ontlastend stoma. Er bleek een aanzienlijke variatie 
tussen ziekenhuizen te bestaan, ondanks correctie voor patient-
en tumorfactoren. Tevens was er een gebrek aan uniformiteit van 
selectiecriteria tussen chirurgen, en kwamen deze niet overeen met de 
factoren die in werkelijkheid bepalend waren.
Interessant genoeg werden factoren gerelateerd aan patiënt-voorkeur 
gemiddeld door chirurgen als minder belangrijk beschouwd. De 
resultaten van dit onderzoek tonen een duidelijke inconsistentie onder 
chirurgen, en onderstrepen de noodzaak van verdere verbetering van de 
huidige besluitvorming rondom de aanleg van het ontlastend stoma, om 
de praktijkvariatie te reduceren.
In hoofdstuk 6 werd onderzocht of het percentage ontlastend stoma 
per ziekenhuis gerelateerd waren aan diens percentage naadlekkage. 
Er bleek geen duidelijke correlatie te bestaan. We vonden vergelijkbare 
percentages naadlekkage in geclusterde ziekenhuizen met een laag (10%) 
en een hoog (85%) percentage ontlastende stomata. Wellicht zijn deze 
eerste ziekenhuizen beter in het selecteren van de hoog-risico patiënt. 
Het heeft de voorkeur de selectieprocedures in deze ziekenhuizen te 
onderzoeken, zodat het gebruik van overbodige ontlastende stomata kan 
worden gereduceerd. 
Deel III : kwaliteitstoetsing van darmkankerchirurgie
Om de kwaliteit van colorectale chirurgische zorg in Nederland te 
monitoren, te evalueren en te verbeteren werd op initiatief van de 
Nederlandse Vereniging voor Heelkunde (NVvH) de DSCA opgericht. 
Hoofdstuk 7 geeft de belangrijkste elementen van de DSCA weer en 
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toont de resultaten van drie jaar clinical auditing. Het artikel richt zich 
specifiek op de elementen die hebben bijgedragen aan de succesvolle 
implementatie, en de centrale rol van de audit in de kwaliteitsbewaking 
van de beroepsgroep. Het format van de DSCA heeft al snel geleid 
tot het genereren van betrouwbare gegevens met volledige landelijke 
dekking binnen twee jaar. De datakwaliteit is hoog; dataverificatie 
met de Nederlandse Kankerregistratie toont een hoog percentage 
overeenkomstige gegevens. In drie jaar vond een aanzienlijke stijging 
plaats in de percentages richtlijnnaleving op het gebied van diagnostiek, 
preoperatief MDO en gestandaardiseerde rapportage gedurende drie 
jaar; het aantal complicaties , re- interventies en postoperatieve sterfte 
nam af. Dit artikel toont dat de ‘blueprint’  van de DSCA kan bijdragen 
aan kwaliteitsverbetering van postoperatieve uitkomsten, en kan dienen 
als voorbeeld voor (internationale) audit-initiatieven.
Bij meten van kwaliteit spelen uitkomstindicatoren een cruciale rol. 
Een uitkomstindicator onderscheidt ziekenhuizen bij voorkeur op 
basis van hun prestaties. Het is derhalve nuttig uitkomstindicatoren 
te identificeren die vooral afhankelijk zijn van behandelings- en 
ziekenhuisfactoren, en in mindere mate worden veroorzaakt 
door verschillen in case-mix. In hoofdstuk 8 werd onderzocht of 
ziekenhuisverschillen in percentage naadlekkage en mortaliteit 
worden veroorzaakt door verschillen in case-mix, of door ziekenhuis 
en behandelingsfactoren. We vonden een ziekenhuisvariatie in zowel 
percentage naadlekkage als mortaliteit. In tegenstelling tot mortaliteit 
was naadlekkage relatief onafhankelijk van verschillen in case- mix. 
Behandelingsfactoren speelden een grotere rol. Beide bevindingen 
maken naadlekkage geschikt als uitkomstindicator voor het meten van 
kwaliteit van zorg.
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